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Summary 
In this thesis we study ventricular-arterial coupling in rodents under the influence of arterial 
stiffening and myocardial infarction (MI), combination of the two considered as a novel 
cardiovascular research model for diseased hearts pumping against an aged, stiffened arterial 
tree. The stiffened arterial tree yields isolated systolic hypertension and is obtained by 
administration of vitamin D and nicotine (VDN). The investigation cardiac performance and 
ventricular-arterial coupling using such a combined model (VDN/MI) is of particular 
relevance to cardiac research, as cardiac disease in elderly often takes place in presence of a 
atherosclerotic or stiff arterial tree.. The thesis consists of an Introduction, 4 scientific papers 
and a brief Conclusion.  
The Introduction is an overview of the epidemiology of heart failure, structure and functional 
changes that occur during MI and VDN, material and methods used in evaluating cardiac 
function invasively and non-invasively (using trans-thoracic echocardiography, TTE), 
methods for evaluating arterial function, and finally an overview of the interaction between 
the heart and vessels.  
Paper 1: This paper addresses the issue of the universality of the normalized time-varying 
elastance curve. It is demonstrated that the waveform of the normalized time-varying 
elastance curve (En(tn)) is qualitatively comparable between the control and MI hearts, 
however, when En(tn) is compared quantitatively between the two groups, statistical 
significance is found at the ejection phase and during diastole. These differences need to be 
taken into account when assessing cardiac contractility based on a generalized En(tn) in 
different animal models or in the human in different physiological or pathological states.  
Paper 2: Using trans-thoracic echo (TTE), we were able to follow serial changes of cardiac 
function post MI using two novel parameters, the myocardioal performance index (MPI) and 
its ratio to left ventricular fractional shortening (LVFS/MPI), both indices being monitor 
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successfully and as efficiently as other classical TTE parameters. More so, LVFS/MPI 
visually expressed better the serial modifications in cardiac function. Both MPI and 
LVFS/MPI were correlated to the load-independent contractile parameter, PRSW, and to the 
preload parameter, LVEDP, being thus pertinent in following preload changes post MI. 
Finally, chamber remodeling post MI can successfully be followed due to the fact that ESV 
and EDV both correlate to MPI and LVFS/MPI.    
Paper 3: We studied hemodynamics, arterial function, cardiac function and ventricular-arterial 
coupling in a rat model of reduced arterial compliance. The results show that arterial 
stiffening after VDN treatment provokes important changes in vascular impedance and wave 
reflections, leading to isolated systolic hypertension and LV hypertrophy, Ventricular-arterial 
coupling was also altered. The effects are quantitatively similar to those of arterial stiffening 
with age. 
Paper 4: We studied changes in cardiac geometry, structure and function in response to MI in 
control and VDN-treated (stiffened aorta) rats. The combined VDN/MI model showed the 
largest compromise in cardiac structure and function and exhibited the strongest biochemical 
signs of heart failure as compared to all other groups. The addition of MI on top of a raised 
afterload, seems to have accelerated the progression of heart failure. Vascular alterations also 
reflected well a model of ageing and calcification. This combined pathology model of failing 
hearts in presence of a stiff arterial tree might be fruitful in better understanding the evolution 
of disease and may help improving or developing novel treatment therapies.  
 
The Conclusion chapter summarizes the findings of the thesis and brings into perspective 
their importance and future relevance into cardiovascular research models. 
 
Keywords: calcium, echocardiography, heart failure, hypertension, myocardial infarction. 
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Résumé 
Dans cette thèse, nous étudions le couple ventriculo-artériel chez les rongeurs sous l’influence 
de rigidification artérielle et d’infarctus du myocarde (IM). La combinaison des deux est 
considérée comme le nouveau modèle de recherche cardio-vasculaire dans le cadre de cœurs 
malades devant pomper dans un arbre artériel âgé et rigidifié. Cet arbre artériel rigidifié se 
focalise sur l’hypertension systolique et est obtenu par administration de vitamine D et de 
nicotine (VDN). Les investigation des performances cardiaques et du couple ventriculo-
artériel utilisant un tel modèle combiné (VDN/IM) sont d’une importance toute particulière 
dans la recherche cardiaque, surtout sous le point de vue des maladies cardiaques liées au 
grand âge, qui recèlent souvent un arbre artériel athérosclérotique ou rigidifié. Cette thèse 
consiste en une introduction, quatre publications scientifiques et une brève conclusion. 
L’introduction fait un tour d’horizon sur l’épidémiologie de l’insuffisance cardiaque, les 
changements structurels et fonctionnels apparaissant durant un IM et la VDN, le matériel et 
les méthodes utilisées pour l’évaluation invasive et non-invasive de la fonction cardiaque 
(échocardiographie trans-thoracique, ETT), les méthodes utilisées pour évaluer la fonction 
artérielle, ainsi que, pour terminer, un point sur les interactions entre cœur et vaisseaux. 
Publication 1) Consacrée à la courbe d’élastance normalisée en fonction du temps. Il a été 
démontré que la forme de la courbe d’élastance normalisée en fonction du temps (En(tn)) est 
qualitativement comparable entre le groupe de contrôle et les cœurs avec IM ; néanmoins, 
lorsque En(tn) est comparé quantitativement, l’on trouve une différence statistiquement 
significative entre la phase d’éjection et durant la diastole. Ces différences sont à prendre en 
compte lors de l’évaluation de la contractilité cardiaque basée sur un En(tn) généralisé pour 
différents modèles animaux ou pour l’être humain dans différents états physiologiques ou 
pathologiques. 
Publication 2) En utilisant l’échocardiographie trans-thoracique (ETT), il nous a été possible 
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de suivre les changements de la fonction cardiaque après IM en nous servant de deux 
nouveaux paramètres, l’index de performance myocardique (IPM) et sa proportion dans la 
fraction de raccourcissement ventriculaire gauche (FRVG/IPM). Tous deux ont été 
monitorisés avec succès et avec la même efficacité que pour les paramètres classique de 
l’ETT. De plus, FRVG/IPM exprime mieux visuellement les changements dans la fonction 
cardiaque. IPM et FRVG/IPM ont été corrélés avec le paramètre contractile indépendant de la 
charge (PRSW), et avec le paramètre de précharge LVEDP, valables pour suivre les 
changements de précharge après IM. Le remodelage des cavités cardiaque après IM peut être 
suivi efficacement grâce au fait que ESV et EDV corrèlent tous deux avec IPM et 
FRVG/IPM. 
Publication 3) Nous avons examinés l’hémodynamique, la fonction artérielle, la fonction 
cardiaque et le couple ventriculo-artériel sur un modèle de rat à compliance artérielle réduite. 
Les résultats mettent en évidence qu’une rigidification artérielle près VDN provoque un 
important changement de l’impédance vasculaire et aussi des réflexions des ondes, conduisant 
à une hypertension systolique isolée et une hypertrophie du VG, ainsi qu’une altération du 
couple ventriculo-artériel. Ces effets sont quantitativement comparables à ceux de la 
rigidification artérielle liée à l’âge. 
Publication 4) Nous avons examinés les changements de la géométrie cardiaque, des 
structures et des fonctions en réponse à un IM, comparé au groupe de contrôle et aux rats 
traités par VDN (aorte rigidifiée). Le modèle combiné VDN/IM montre le plus grand 
compromis dans les structure et fonction cardiaques et montre les signes biochimiques 
d’insuffisance cardiaque les plus marqués en comparaison avec tous les autres groupes. 
L’ajout d’un IM sur une postcharge augmentée semble accélérer l’apparition d’insuffisance 
cardiaque. Les altérations vasculaires reflétaient bien un modèle de vieillissement et de 
calcification vasculaire. Cette combinaison de modèles pathologiques d’insuffisance 
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cardiaques en présence d’un arbre artériel rigidifié pourrait aider à mieux comprendre 
l’évolution de la maladie et pourrait contribuer à l’amélioration ou au développement de 
nouvelles thérapies. 
 
Le chapitre de conclusion fait le bilan des résultats obtenus dans cette thèse et met en 
perspective leur importance présente et future dans les différents modèles de recherche 
cardiovasculaire. 
 
 
Mots-clés : calcium, échocardiographie, insuffisance cardiaque, hypertension, infarctus du 
myocarde. 
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Introduction 
Heart failure in relation to myocardial infarction and hypertension 
One of the most cited and a coherent study on the epidemiology of congestive heart failure 
(CHF) in the USA is The Framingham Heart Study, which followed a cohort of 9405 patients 
over a 40 year period [20]. In a subgroup analysis of 331 men and 321 women who developed 
CHF, the majority had coronary artery disease (CAD) with or without hypertension (HTN), 
and approximately 1/3 had HTN alone.  
Epidemiological studies have shown that coronary heart disease (CHD) and essential 
hypertension are independent predictors of congestive heart failure with an occurrence rate of 
40% in both male and female populations when the two pathologies are combined (Figure 1)[ 
20]. Figure 1 demonstrates the risk of several conditions on the development of CHF in men 
with a similar occurrence in woman. Serum cholesterol was not associated with an increased 
risk of HF. However, smoking, HTN, diabetes and ECG-LV hypertrophy did. There were also 
age-dependent differences in risk rates. Therefore, the combination of myocardial infarction 
(MI) together with hypertension would also seem to be an interesting research model to 
pursue. 
 
 
 
 
 
 
 Figure 1 Demonstrates the risk of several conditions on the development of CHF in men with a similar 
occurrence in woman.  
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Physiology of myocardial infarction (MI) and hypertension (VDN) 
Despite the multiple different causes, LV failure typically progresses by the common 
pathways of myocyte hypertrophy, fibrosis deposition, and left ventricular chamber 
enlargement. Abnormalities of function during systole, diastole or both may contribute to 
diminished cardiovascular performance. The evolution of cardiac function depends on the 
pathology inflicting the damage.  
Figure 2. Schematic representation of 
the two models of pressure and volume 
overload.  
Myocardial Infarction (MI) causes chamber dilatation and loss in contractile function often 
referred to as “volume overload” while HTN raises the afterload of the heart and causes a 
state called “pressure overload”. These two models lead to different changes in cardiac 
function as a response to workload. A pattern of hypertrophic growth characterized as 
concentric, in which increased mass is out of proportion to chamber volume, is particularly 
effective in reducing systolic wall stress under 
conditions of increased pressure load. In contrast, in 
volume overload conditions, in which the major 
stimulus is diastolic loading, a predominant finding is 
a great increase in the cavity volume or size, the 
relationship between mass and volume is either 
preserved or, in severe cases, reduced. The 
fundamental response is generated by cellular 
hypertrophy. However, the configuration of the new 
contractile tissue is specific and offsets the major 
mechanical stimulus of pressure or volume overload 
(Figure 2)[16]. 
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During aging, alterations in aortic structure and function occur, leading to a decrease in aortic 
compliance. Degeneration and fragmentation of elastic fibers contribute to the increase in 
aortic stiffness [4]. To study the effects of arterial stiffening on arterial and cardiac function, 
many experimental animal models have been used, ranging from acute animal models where 
the aorta was either replaced by a stiff tube [26,42] or wrapped with a non-compliant Dacron 
band [21], to chronic models, where aortic stiffness is increased by inbreeding [19], as a result 
of hypertension-induced remodeling [23] through some chemical or biological treatment or 
old age [4,12,32]. Of particular importance is a model of aortic elastocalcinosis induced by 
the administration of vitamin D3 and nicotine (VDN), developed originally by Hass et al. [18]. 
The VDN model leads to arterial stiffening by decimation of the arterial wall elastic fibre 
network [38]. Earlier studies on the effects of VDN on arterial hemodynamics showed that 
arterial stiffening caused by VDN decreased compliance and increased wave speed, aortic 
characteristic impedance, and wave reflections leading to isolated systolic hypertension (ISH) 
and the development of compensatory LV hypertrophy [28,29]. 
 Thus, the type of remodeling occurring in the combined model (MI and ISH provoked 
by VDN) would be interesting to elucidate and understand the mechanisms involved in its 
development. The cardiac function can be modeled invasively (using the conductance 
catheter, CC) and/or non-invasively using trans-thoracic echocardiography (TTE)[5,62].  
 
Cardiac function using conductance catheter: Invasive measurements 
The cardiac cycle in brief 
The principle function of the heart is to pump oxygenated blood to the peripheral tissues to 
meet their metabolic demands. The systemic arterial and venous systems provide the conduits. 
The interaction of the LV with the arterial and venous systems is therefore integral to the 
satisfactory performance of this vital function. It is important to understand how the normal 
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heart functions and how it interacts with the systemic arterial and venous systems as prelude 
to comprehending how it is affected by various pathologic conditions.  
In brief, the cardiac cycle, with 
electrical activation there is an 
abrupt increase in isovolumic LV 
pressure, followed by rapid 
ejection. Reduced ejection follows 
until closure of the aortic valve, 
establishment of zero flow, 
minimal volume, and maximal LV 
wall thickness, at which time 
diastolic events are initiated. The 
initial diastolic event, active LV pressure decline, is followed by rapid filling, which 
manifests as a rapid increase in LV volume and thinning of the LV wall, followed by 
diastasis. Diastole is completed with atrial contraction (Figure 3)[6].  
Figure 3. The cardiac cycle representing the different 
phases within it.  
 
The pressure-volume relationship 
The diastolic and systolic pressure-volume (P-V) relations can be obtained in vivo by 
measuring ventricular volume and pressure while cardiac filling is changed, for instance by 
partial occlusions of the vena cava which is, in fact, the preferred way to obtain the ESPVR 
(Figure 4). At each moment in the cardiac cycle a P-V graph exists, which can be obtained by 
constructing isochrones. This family of curves, when approximated by straight lines, allows 
for the determination of slope as a function of time, E(t) [58]. The time pattern of this slope, 
E(t), when normalised with respect to magnitude and time to peak (En(tn)), is maintained 
under normal conditions and during diseased states like MI [40]. From the P-V loops, the E (t) 
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(Figure 4) and En(tn) curves [58] can be established, as well as the functional parameters [10, 
51] and finally the cardiac energetics [59-61](Figure 5). In MI induced HF, the ESPVR is 
compromised contrary to the initial effect of HTN, which causes enhanced contractility thus a 
higher ESPVR.  
Sagawa et al. performed various preload, afterload, ino and chronotropic manipulations in a 
canine model and came to the conclusion that the LV has time-varying elastic characteristics 
and elastance is maximal at end-systole [50]. During different cardiac pathologies, the E(t) 
curve is presumed to be conserved; however, this is a controversial topic as Kass et al. 
describes this phenomenon [25]. However, we hypothesise, that MI does in effect alter the 
E(t) curve.  
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Figure 4 Pressure-volume relationships during control and epinephrine stimulation.  
 
Energetics: total mechanical energy and PVA 
Suga et al. came to the conclusion that the E (t) can lead to a new measure of total mechanical 
energy of contraction as an analogy of the mechanical energy stored in a stretched spring and 
mechanical work performed by its shortening (Figure 5C) [50]. This measure corresponds to 
the systolic P-V area (PVA) in the P-V diagram (Figure 5D,E). PVA is the sum of the areas 
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for external work (EW) within the P-V loop and elastic potential energy (PE) under the Emax 
line on the origin side of the P-V loop. Consequently, Suga et al. established the relationship 
between PVA and myocardial oxygen consumption (mVO2)[58]. Efficiency is inversely 
proportional to PVA.  
 
 
 
 
 
 
 
F igure 5. Information contained in the P-V diagram. Ventricular contractility index Emax (A), time-varying 
elastance E(t) (B), external work (EW) and potential energy (PE) in the time-varing elastance model of the 
entricle (C), and systolic PVA (shaded area) as a measure of ventricular total mechanical energy in isovolumic 
) and ejecting contraction (E). Vo: unstressed ventricular volume, ES: end systole, ED: end diastole. 
v
(D 
Assessment of LV function 
dP/dtmax is the most widely used index of contractility, assumingly afterload independent but 
sensitive to preload. Its relationship with EDV is linear and is load independent. However, a 
more useful indicator, ESPVR is preload and afterload independent [51]. ESPVR can be 
characterized by a slope (Ees) and a volume axis intercept (Vo), so that Pes=Ees(Ves-Vo). 
The Vo is the volume left in the LV when no load is applied. ESPVR can also vary with heart 
size so normalization has been considered [61].  
Cardiac output (CO), ejection fraction (EF), left ventricular fractional shortening (LVFS) and 
stroke work (SW) are all load dependent. However, SW can be indexed to EDV becoming 
preload recruitable stroke work (PRSW) which is sensitive to contractile changes but 
insensitive to pre, afterload and heart size.  
Tau (τ), an index of isovolumic relaxation, is defined as the time required to decline 1/e or 
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37% of its value at dP/dtmin. EDPVR is a measure of diastolic stiffness and is influenced by 
EDV. It can be linear or nonlinear depending on the filling pressure. It reflects the net effect 
of all facets of myocardial material properties, chamber structure properties, and extracellular 
matrix [10]. 
 
Cardiac function using Trans-Thoracic Echocardiography (TTE): non-
invasive measurements 
The use of TTE has already been validated in rats [44], using different models including MI 
[22,33,41], hypertension and aging [55], and a comparison between both pressure-volume 
overloaded ones [13]. The M-mode (Figure 6) is used to evaluate parameters which utilise the 
following dimensional parameters seen in Figure 6 i.e. end-diastolic LV dimension (LVDed), 
end systolic LV dimension (LVDes), septal and posterior wall thickness’s (SWth and PWth 
respectively). 
Indicators of systolic function: 
1. Ejection fraction (EF): A 2-dimensional long axis view is obtained during end-systole and 
end-diastole of the LV. The images are sectioned and a length, L is obtained. The 
following formula is applied: (EDV-ESV)/EDV= % where the volumes are calculated 
from: ( π/ 4) • Σ D • (L / n)    where n = 20 discs of diameter D. This is referred to as the 
Simpson rule (Figure 7).  
2. LV fractional shortening (LVFS): (LVDed-LVDes)/LVDed x100= %. LVFS is preload 
and afterload dependent.  
3. LV mass: (((LVDed+SWth+PWth)3LVDed3)*1.04)*0.8+0.14 = g  
4. Relative wall thickness (RWT): (PWth+SWth)/(LVDed) 
5. Velocity of circumferential fibre shortening (Vcf) : (LVDed-LVDes)/(ET x LVDed)= 
circ/s 
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6. Myocardial performance index (MPI): an indicator of combined systolic and diastolic 
function (Figure 8)[63]. It comprises of the isovolumic contraction time (ICT) plus 
isovolumic relaxation time (IRT) divided by the ejection time (ET).  
12
3
4
Figure 6. Representation of the M mode 
showing the LVDed (1), LVDes (2), SWth (3) 
and PWth (4). 
Figure 7. Representation of the Simpson rule 
showing the LV in diastole (left) and systole 
(right). 
Figure 8. Sketch showing the principle of the 
MPI.  
7. Cardiac output (CO): Instantaneous blood flow: Vmax (cm/s)  •  A (cm2)   =   Q (cm3/s)= 
ml/s x 60 = ml/min.  
 
Indicators of diastolic function: 
Diastolic function is assessed indirectly from flow across the mitral valve and by pulmonary 
venous flow (Figure 6). The E wave is developed from early atrial filling and the A wave 
   
from atrial contraction. Their ratio is often used to express an indication of diastolic function 
in a clinical setting but has certain limitations. In rats, the major limitation is the high HR 
which causes the two waves to fuse thus rendering the analysis impossible. Therefore, this 
parameter is inappropriate. Other parameters exist but require Doppler tissue imaging (DTI) 
or strain functions, which need to be installed in the TTE machine or special probes are 
necessary.  
Thus, we opted to analyze the flow in the pulmonary vein. The parameter that is well known 
to correlate to any alterations in left atrial pressure being a sign of diastolic dysfunction is the 
deceleration time of the D (diastolic) wave (Figure 9)[27]. 
 
 
 
 
 
 
 
 
Figure 9. Doppler transmitral (above) and pulmonary (below) venous flow patterns with diastolic 
dysfunction. In healthy young individuals, most diastolic filling occurs early in diastole so the E/A 
ratio is >1. The relaxation is impaired, early diastolic filling decreases, and more blood is 
transported late in diastole by atrial contraction; this is reflected by E/A reversal. With disease 
progression, LV compliance decreases and filling pressure increases (pseudonormalisation). With a 
severe decrease in LV compliance, left atrial pressure rises maintaining diastolic filling that result in 
a restrictive pattern.  
 
 
 
Arterial function including wave reflection analysis: effects of HTN 
Epidemiological studies have emphasized the close relationship between elevated 
blood pressure and the incidence of cardiovascular disease [64]. Systolic blood pressure and 
pulse pressure (PP), in particular, have been demonstrated to be strong independent predictors 
of cardiovascular mortality [15,47]. PP is on one hand determined by heart-related parameters 
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such as heart rate and stroke volume (also related to arterial load), but also by the cushioning 
capacity of arteries (total arterial compliance) and the timing and intensity of wave reflections 
[37,57]. The former is influenced by arterial stiffness, which is usually expressed as the 
inverse of stiffness, i.e., as compliance or distensibility. The latter results from the summation 
of all backward running waves i.e., waves returning towards the heart after reflection at 
peripheral sites. In a recent review, aortic stiffness (measured from aortic pulse wave velocity, 
PWV) and an early return of reflected waves to the heart have been established as 
independent predictors of cardiovascular risk [48].  
Aging, environmental and genetic factors are responsible for structural and functional 
changes of the arterial wall, leading to decreased elasticity and increased stiffness in humans 
[17,36]. Furthermore, these changes in arterial stiffness are different in proximal elastic 
arteries compared to distal muscular ones [7,30,39]. This increased stiffness, is responsible for 
raising the systolic blood pressure and a relative decrease is diastolic blood pressure, thus 
increasing pulse pressure (PP). More specifically, increased PP, stiffness and thickness of the 
common carotid artery (CCA) wall were shown to be significant predictors of cardiovascular 
complications mainly for myocardial infarction [9] but also for stroke in humans [31]. 
Similarly, the relationship between raised CCA stiffness and left ventricular (LV) hypertrophy 
has been established [8,45,46].  
Assessment of arterial function. Aortic flow is measured using a transit-time 
ultrasonic flowmeter with the flow probe placed around the ascending aorta. Aortic pressure 
is measured by retracting the CC from the LV into the ascending aorta. Steady state 
measurements containing 10 cycles are averaged to construct a representative steady-state 
beat of aortic pressure (Pao) and flow (Qao). Discrete Fourier transform (Mathematica 5.2®, 
Wolfram Research Inc., IL, USA), is applied to obtain pressure and flow in the frequency 
domain.  Aortic input impedance, Zin, was calculated as the ratio of the pressure to flow 
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harmonics and we considered the steady (or DC component) and the first 10 harmonics.  
The ratio of mean Pao and Qao (DC component of Zin) is systemic vascular resistance (R). 
Input impedance being a complex quantity, is expressed in terms of its modulus and phase as 
a function of frequency (figure 10 top). The characteristic impedance of the aorta, Zc, is 
estimated as the average of impedance modulus between the 5th and the 10th harmonic. 
Because heart rate differs from animal to animal, impedance values are interpolated and 
reported at intervals of 10Hz, allowing thus the calculation of standard deviations. Total 
arterial compliance (C) is estimated using the Pulse Pressure Method [56]. Pulse wave 
velocity (PWV) is estimated indirectly from the characteristic impedance and ascending aorta 
dimensions as PWV= Zc*A/ρ, where A=πr2 is the luminal cross-sectional area of the 
ascending aorta measured with Echo Doppler and ρ  being the density of blood.  
 
 
 
 
 
 
 
 
 
 Figure 10. 1) Impedance at zero freqzuency or peripheral resistance (R). 2) Mean value of impedence moduli or 
characteristic impendence (Zo). Zo is an index of aortic elastance. 3) Fundamental impedence moduli Zi, is an 
index of wave reflection amplitude Ps-Pi; reflectance. Impedence minimum is related to PWV and distance to the 
major reflection site. (lower left) High fidelity pressure and flow velocity waveforms. Ps is peak systolic 
pressure, Pi is inflection point, which indicates the beginning of the upstroke of reflected pressure wave, and Pd 
is diastolic pressure. ∆tp is roundtrip travel time of the forward wave from ascending aorta to major reflecting 
site and back. The shaded area represents the part of the respective wave that is reflected. SVr is the stroke 
volume associated with the reflected flow wave i.e. that would be ejected in a reflectionless system. (lower right) 
Venn diagram showing three components of afterload.  
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The assessment of arterial function has already been documented in mice and rats and is 
found to be affected by HTN [43,48,52]. Changes in arterial function also affect afterload 
which in turn is influenced by internal stresses (stress, viscous resistance, inertial 
components) and external vascular load (C, Z, R). In HTN, the impedence modulus is raised 
(Figure 11a) while in aging the arterial waveform is also modified (Figure 11b)[53,54].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11a.  In hypertension, R and MAP are 
increased (4). C drops resulting in a less rapid 
decrease in Z, with frequency, 1, and a higher Zc, 2. 
PP rises (1,2). Wave speed rises  and Z oscillates 
around Zc (3), and the wave is augmented (3) 
Figure 11b. Analysis of aortic pressure waves  
with their forward (dashed lines) and reflected, 
or backward waves (dotted lines). The type C 
beat pertains to young and the Type A beat to 
an old subject. 
Wave reflection analysis. Aortic pressure, Pao, is separated into its forward (Pf) and 
backward (Pb) running components using the linear wave separation method [65]: 
Pf = (Pao + Zc * Qao) /2  and Pb = (Pao − Zc *Qao) /2 
An example of the aortic pressure wave and its forward and backward (reflected) components 
is shown in figure 11b. The backward component is the sum of all reflected waves travelling 
towards the heart [65]. To characterize wave reflections, the reflection coefficient (Γ) was 
computed as [66]: 
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Γ = (Zin − Zc) /(Zin + Zc) 
Γ is a frequency-dependent complex quantity. In order to facilitate comparison between 
pathologies one can compute and compare the modulus of the reflection coefficient at the 1st 
harmonic, |Γ1| which is assumed to be representative of the general wave reflection properties 
of the arterial tree. The time of the arrival of the foot of the reflected wave was defined as ∆t 
(Figure 10). The shorter the ∆t, the stronger the systolic pressure augmentation resulting from 
wave reflections.  
The cushioning effect of arteries. The principal role of arteries as cushions is to 
dampen the pressure oscillations that are caused by the intermittent nature of ventricular 
ejection [36].  
In performing this cushioning function, the arterial system is able to instantaneously 
accommodate the entire volume of blood ejected from the heart during systole. Arteries store 
part of the stroke volume during systolic ejection and drain it during diastole. This so called 
“Windkessel function” diminishes the pulsatility of the flow. Under normal conditions during 
systole, roughly 40% of stroke volume is forwarded directly to peripheral tissues, whereas the 
remainder (60%) is stored in the capacitive arteries (aorta and major arteries), distending the 
walls and storing part of the energy to be available during diastole (Figure 12). In diastole, the 
stored energy recoils the aorta, squeezing the stored blood forward into the peripheral 
circulation.  
 
 
 
 
 
 
Figure 12           Figure 13 
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When there is decreased arterial distensibility, a greater proportion of the stroke volume is 
forwarded to the peripheral circulation (50%), and less can be cushioned in the arterial bed 
during systole (50%)(Figure 13). Consequently, the amplitude of the arterial pulse wave and, 
inherently, systolic blood pressure, are increased. After the closure of the aortic valves, 
arterial pressure begins to fall as blood is drained to the peripheral arteries. The minimum 
diastolic blood pressure is determined by the duration of the diastolic interval (heart rate) and 
the rate at which the pressure falls. The rate of pressure fall is influenced by the rate of 
outflow (i.e., peripheral resistance) and by the compliance of the arterial tree, the product of 
the two defining the diastolic decay time. Consequently, at a given vascular resistance, the fall 
in diastolic blood pressure will also be greater if the stiffness of large arteries is increased.  
In contrast, increased total peripheral resistance decreases systolic run-off (to perhaps 30% or 
less of stroke volume) so that a much higher proportion is stored in the capacitive arteries. 
Consequently, diastolic run-off is increased (70%), producing an elevation of mean blood 
pressure in parallel to an increase in pulse pressure (Figure 14). 
 
 
 
 
 
 
 
 Figure 14              Figure 15 
The mechanical properties of arterial walls are also determinants of the propagation and 
reflection of pressure waves along the arteries. Ventricular ejection generates a primary (or 
incident) pressure wave that moves away from the heart at a finite speed, termed pulse wave 
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velocity, which increases with arterial stiffening. The incident wave is reflected at any point 
of structural or geometric discontinuity of the arterial tree, generating a reflected wave 
travelling backward toward the ascending aorta [34,36]. Thus stiffening of the arteries 
increases the pulse wave velocity and may be responsible for an earlier return of reflected 
waves. This means that reflected waves may return during the systolic phase rather than the 
diastolic phase, thus augmenting the systolic part of the incident pressure wave and 
contributing further to the increase in systolic blood pressure (Figure 15). 
 
Interaction between heart and vessels: ventricular-arterial coupling 
Arterial elastance (Ea) is calculated as the ratio of Pes divided by SV and the coupling 
parameter Ea/Ees is often computed as an indicator of ventricular-arterial coupling (Figure 
16)[58]. Ventricular-arterial coupling is often judged upon optimal cardiac energetics, i.e., the 
ability of the heart to deliver optimal power or operate under maximal efficiency [65] 
characterized by the ratio of Ea/Ees. It has been suggested that the heart delivers maximum SW 
when Ea/Ees =1, whereas optimal efficiency is obtained when Ea/Ees =0.5 [11]. As the ratio 
augments above 1.3 and below 0.3, the SW and efficiency are both compromised [25] as 
observed in patients with severe cardiac dysfunction [3]. Efficiency, defined as the ratio of 
stroke work over pressure-volume area (stroke work plus potential energy) is calculated. Two 
other important ventricular-arterial coupling parameters are computed: first, the “Compliance 
Coupling Index, CCI” expressed as the product of characteristic chamber elastance (EesxC), 
Ees being the inverse of ventricular compliance at end systole and C arterial compliance. 
Second, the “Temporal Coupling Index, TCI”, expressed as the ratio of characteristic times 
(RC/T), T being the heart period and RC the characteristic diastolic pressure decay time 
which is a combination of the capacitive-resistive properties of the arterial tree [57].  
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 Figure 16. Ventriculo-arterial coupling in terms of Ea/Emax ratio. A: Ea/Emax ratio is 
comparable to 1 in normal hearts with a high EF. B: Ea/Emax ratio increases from 1 as 
heart failure proceeds with EF dropping.   
Scope and overview of a novel model using MI and VDN 
Most experimental models of hypertensive rats developed in the past were based on essential 
hypertensive principles and not on isolated systolic hypertension (ISH). Early reports of 
combined models of hypertension and MI were by Fletcher et al., who used spontaneously 
hypertensive rats (SHR) together with MI [14]. Others used renal hypertensive models [2,35], 
aortic banding [1] and Dahl salt-sensitive and salt-resistant rats [24]. Alternatively, a 
mechanical model in an acute setting was studied in dogs, whereby thoracic aorta was 
replaced by a plastic tube, to mimic severe aortic stiffening during the aging process [26].  
The use of ISH together with MI has not been pursued in the cardiovascular research 
community, whereas, in reality, MI takes place often in aged individuals with stiff arterial 
trees and ISH. Thus, we found it to be instructive to develop a novel model of MI together 
with ISH using VDN. The following two hypotheses were central in defining the scope and 
focus of the thesis: We hypothesized that: 1) the effects of MI on cardiac function and 
transition towards HF may be enhanced/accelerated when in presence of a stiff arterial tree, 2) 
the combination of MI and ISH may represent a novel small animal model of HF that mimics 
the patho-physiological alterations found in clinical situations. 
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Abstract 
 
It has been suggested that the wave shape of the normalized time-varying elastance curve, 
En(tn), is conserved in different cardiac pathologies. We hypothesize that the shape of the 
En(tn) is conserved but that its slopes during systole and diastole as well as its end diastolic 
value differ quantitatively during heart failure provoked by myocardial infarction (MI).  
Sprague-Dawley rats (n=7) were anesthetized with 3% Isofluorane and the left anterior 
descending coronary artery was ligated to provoke the MI. A sham operated control group 
(CTRL) (n=9) was treated without the infarction. Two months later, a Conductance catheter 
was inserted into the left ventricle. The ventricular pressure and volume were measured and 
the En(tn) derived. Preload recruitable stroke work (PRSW), ejection fraction (EF), end 
diastolic pressure (EDP), minimum (Vmin) and maximum (Vmax) LV volumes, relaxation 
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constant (tau), slope of the En(tn) during the Pre Ejection Period (PEP), Ejection time (ET) 
and Isovolumic relaxation (IVR) period and normalized minimum elastance (E*min) were 
analyzed and compared between the two groups.  
Contraction and relaxation times were compromised in the MI group (p<0.05). PRSW and EF 
were reduced in the MI group (p<0.05). The EDP, Vmin and Vmax were enlarged in the MI 
group due to diastolic dysfunction and chamber dilatation (p<0.05). Tau increased in the MI 
group (p<0.05). The slope of the En(tn) curve during ET, IVR and the complete diastolic phase 
were different (p<0.05). Further, E*min was significantly augmented in the MI group. 
We conclude that the En(tn) although similar in shape, differs quantitatively between normal 
and failing hearts provoked by MI.  
 
 
 
 
Keyword: compliance, ischemia, contractility, ventricular function, hemodynamics, conductance 
volumetry 
Introduction  
 
Heart failure is the condition in which the heart cannot pump sufficient amounts of 
blood to sustain the body’s metabolic needs and perfusion of vital organs [14]. It is therefore 
important to know what the pump function of the heart is in health and diseased states. One 
description of the heart’s pump function is with the use of the End-Systolic Pressure-Volume 
Relation (ESPVR). At the basis of the ESPVR stands the varying elastance concept, whereby 
the time varying elastance, E(t), gives a time-domain description of the heart pump function 
[19]. 
The shape of the normalized time varying elastance curve (En(tn)) has been shown to 
be similar in different animal species [4]. It has been reported that when E(t) is normalized 
with respect to peak value and peak time, the shape (wave form) of the En(tn) is independent 
of different cardiac pathologies, afterload, preload, and contractility [17]. We went about 
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testing whether the En(tn) is indeed independent of cardiac diseased state. For this purpose, we 
studied the infarcted rodent in terms of pressure-volume relation and derived the En(tn) for 
control (sham operated) rats and rats where failure is provoked by coronary artery ligation. To 
test this hypothesis, the normalized elastance values are compared between the control and MI 
group.   
 
Materials and methods  
 
Animals. Male Sprague-Dawley rats were purchased from Charles River Breeding 
Laboratories (France). They were maintained in temperature and humidity controlled rooms 
with typical light-dark cycle and given standard chow and tap water ad libitum. All rats were 
handled in accordance with the Guide for the Care and Use of Laboratory Animals published 
by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and our 
Institutional Animal Care and Use Committee approved the protocol.  
Experimental MI. The myocardially infarcted group (MI) consisted of Sprague-
Dawley rats (n=7) with a body weight of 254±19g. The rodents were anesthetized with 3% 
Isofluorane (Forene, Abbott AG, Baar, Switzerland), intubated then ventilated with 100% 
oxygen at 60 cycles per minute with a tidal volume of 2ml (Harvard Apparatus Inc model 
683, Holliston, Ma, USA) before the surgical procedure was performed. The rats were placed 
on a heating pad to maintain body temperature and disinfection performed of the thorax. A 
left thoracotomy was performed at the 3rd intercostal space to gain access to the heart. The 
pericardium was opened and the left anterior descending coronary artery was located, between 
the left atrium and the pulmonary artery, ligated with a 4.0 Polypropylene (Ethicon 
Somerville, NJ, USA) to provoke the MI. This was confirmed by a change of color of the left 
ventricle from red to a purplish/grey distal to the ligation.  
The ribs were closed with 2-3 ligatures, a chest drained inserted to avoid any pneumothorax 
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and the muscles surrounding the rib cage were closed before the skin was closed. Analgesia 
was given (Pro-Dafalgan) in order to attenuate any pain ensued by the rodents due to the MI 
(20mg, Upsamedica SA, Baar, Switzerland). The anesthesia was gradually weaned and when 
the rat began to awaken and spontaneous breathing resumed, the intubation tube was 
removed. The rats were then returned to the animal house once complete recovery was 
observed.  A similar sham operated control group (CTRL) (n=9) with the rodents weighing 
238±7g was performed without the myocardial infarction. 
Hemodynamic measurements and pressure-volume curves.  Eight weeks after the 
initial operation the rats were again anaesthetized and intubated. The right neck region was 
disinfected to provide access to the carotid artery. The skin was opened and the right jugular 
vein and carotid artery were isolated. A conductance catheter (Aria®, Millar Instruments Inc, 
Texas, USA) was inserted into the left ventricle via the right carotid artery. Parallel 
conductance was measured after injection of 10% saline into the jugular vein using a 1ml 
syringe (20µL Natrium chloratum, Sintetica SA, Mendrisio, Switzerland) in accordance to the 
method by Baan et al [1]. Alpha was validated with trans-thoracic echocardiography and was 
found to be 3. An occlusion analysis was performed by temporarily occluding the inferior 
vena cava below the diaphragm via a mini laparotomy. Figure 1 (left) shows pressure-volume 
loops recorded during such an inferior vena cava occlusion for a control rat.  
 
 
 38
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 100
Time (ms)
E
l
a
s
t
a
n
c
e
 
(
m
m
H
g
/
µ
L
)
Ees 
(CTRL)
Ees 
(MI)
0
20
40
60
80
100
120
140
0 100 200 300 400 500 600
Volume (µL)
P
r
e
s
s
u
r
e
 
(
m
m
H
g
)
CTRL
MI
ESPVR
CTRL
ESPVR
MI
 
Figure 1 (left). Occlusion analysis compared between the CTRL (grey) and the MI group (black) showing elevated Emin (EDPVR) evident of raised EDP and a reduced SV 
because of HF with maintained Emax (ESPVR).  
Figure 1 (right). The TVEC extrapolated from the occlusion analysis is visible above taken from a CTRL (grey) and MI (black) rat.  
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On the same graph are shown the End-Systolic Pressure-Volume Relationship 
(ESPVR) and End-Diastolic Pressure-Volume Relationship (EDPVR), which are assumed to 
be linear and whose slopes define the maximum (Emax) and minimum (Emin) elastance, 
respectively. E*max and E*min denote normalized values. The linear ESPVR intercepts the 
volume axis at V0. Assuming that V0 does not change during the heart cycle, we can define 
the instantaneous elastance, E(t) or TVEC as E(t) = Pv/(V(t)-V0 ). A typical waveform for the 
TVEC is shown in Figure 1 (right). 
 
From steady state pressure-volume recordings we derived the following parameters: heart rate 
(HR), stroke volume (SV), cardiac output (CO), end systolic pressure (ESP), end diastolic 
pressure (EDP), end systolic volume (ESV), end diastolic volume (EDV), ejection fraction 
(EF), contraction time (duration of the isovolumic contraction), contraction index (maximum 
dP/dt divided by pressure at this point), and relaxation time (duration of the isovolumic 
relaxation) and Tau defined as the time required for LV pressure to decline 1/e or 37% of its 
value at dP/dtmin.  
The following parameters were also derived from the pressure and volume data: Preload-
Recruitable Stroke Work (PRSW), defined as the slope of the area of the pressure-volume 
loop vs. end diastolic volume (EDV), dP/dtmax and the preload adjusted dP/dtmax (dP/dtmax vs 
EDV), both used in the literature as indices of contractility [16]. 
Normalized time varying elastance curve. The normalized time varying elastance 
curve, En(tn), was obtained by way of E* = E/Emax and t* = t/tmax  (*= normalized). A typical 
En(tn) is represented in Figure 2.  
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Figure 2. The En(tn) with the relevant slopes used for calculating α (iso), α (eje), the exponential decay time (е –
t/τ) and Emin. The exponential decay time is not the same as tau calculated by the CC.  
 
Comparison of the En(tn) curve between the CTRL and MI group is done at two levels. 
First, on a point-by-point basis, by comparing the values of the E* at the same 
nondimensional time t*, t* varying over the entire cardiac cycle at 0.1 intervals. Second, by 
comparing four different parameters characterizing the En(tn), namely a) the slope of the pre-
ejection period (PEP), b) the slope of the ejection period (EP), c) the characteristic time of the 
exponential decay during early diastole and d) its end-diastolic value, E*min. These parameters 
are shown schematically in Figure 2. The PEP slope is denoted as αiso and the ET slope as αeje. 
The exponential decay time during early diastole (е –t*/τ, 1.1≤ t* ≥1.5) was used to find the 
constant τ. The start of the PEP being the moment when LV dP/dt exceeds 30% of positive 
dP/dtmax to focus the linear part of E(t) during the isovolumic contraction phase. The end of 
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the PEP is defined as the moment when the steep rise of the aortic pressure begins. The end of 
the ET is defined as the time when dP/dt decreases to 20% of dP/dtmin.  
Beta (β) was also derived and defined as the ratio of the two systolic slopes (αeje /αiso). The 
mean and SEM were calculated for each group and compared using an two tailed Student’s t-
test. Statistical significance considered when p<0.05(*) or p<0.01(†).  
 
 
Results  
 
Hemodynamic parameters. Hemodynamic parameters for the CTRL group and the MI 
group are shown in Table 1. Statistical significance at p<0.05 (*) and p < 0.01 (†) is also 
shown. Heart failure has caused the EDP to double and EDV increased by 33%, indicative of 
chamber dilation (p<0.05). SV decreased by approximately 30% (p<0.05) and ESV doubled 
(p<0.01). Ejection fraction decreased significantly, from 60% to 36% (p<0.01). Cardiac 
output decreased by 33% (p<0.05).  
Heart rate, Emax and Emin were not different between the CTRL and the MI group 
(Table 1). Due to dilation, the intercept volume V0 increased significantly (p <0.01) (Table 1). 
Despite a 10% decrease in the average value, dP/dtmax did not change significantly between 
the two groups. The slope of the dP/dtmax-EDV curve as well as Preload Recruitable Stroke 
Work, however, did decrease significantly in the MI group (Table 1). Contraction and 
relaxation times were prolonged and contractility index was reduced in the MI group by 21% 
as compared to the CTRL group (p<0.01 for all, Table 1).  
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Table 1.Cardiac and arterial functional parameters processed from the conductance catheter. CTRL (Control group) and MI (Myocardial infarction group) with statistical 
   Contractile parameters 
 
Ees 
(mmHg/µL) 
Emin 
(mmHg/µL) 
E*es LV mass 
(mmHg/(µL/g)) 
E*es EDV  
(mmHg) 
E*es BW 
(mmHg/µL/kg)
E*min LV mass 
(mmHg/µL/g) 
E*min ESV 
(mmHg) 
dP/dt max-EDV 
(mmHg/ms/µL) 
PRSW 
(mmHg) 
Contractility 
index (s-1) 
dP/dt max 
(mmHg/ms) 
dP/dt min 
(mmHg/ms) 
CTRL 0.96±0.2          
           
        
   
    
    
    
       
   
         
         
significance considered when p<0.05* and p<0.01†. 
0.05±0.03 0.85±0.19 0.57±0.17 490±140 0.04±0.03 5.6±2.8 26.8±10.9 70±17 95.7±6.7 5128±1241 -4722±725
MI 0.99±0.2 0.08±0.12 1.10±0.24* 0.78±0.24* 490±240 0.07±0.09 18±15* 18.9±6.9*
 
50±17† 
 
76.3±11.6† 4606±1407 -4406±1200
Volumetric 
parameters 
Timing  
parameters 
 SV (µL) CO (ml/min) EDV (µL) ESV (µL) EF (%) Vo (µL)  SEP (ms) DFP (ms) ICT (ms) IRT (ms) Tau (ms) 
CTRL 300±120 108±45 450±90 180±30 60.3±2.6       -76±74  51.3±8.2 60.9±12.7 17.4±1.0 46.4±0.6 6.0±0.3
MI 210±90* 72±33* 600±150* 390±180† 35.9±16.6† 54±92†
 51.4±7.8 57.8±13.8 20.1±2.0† 53.6±5.1† 14.6±5.6†
Physiological 
parameters 
 
Coupling 
parameters 
 
Body weight 
(kg) 
LV mass (g) 
LV mass/Body 
weight (g/kg) 
Lung weight 
(g) 
Heart weight 
(g) 
Psys (mmHg) 
LVEDP  
(mmHg) 
HR (bpm)  Ea Ea/Ees  
CTRL 0.48±0.03 0.85± 0.12 1.75±0.21 0.76±0.26 1.44±0.07 74.8±9.6 3.33±1.3 350±35 0.86±0.44 0.86±0.36  
MI 0.42±0.03† 1.03±0.15† 2.51±0.52† 0.79±0.29 1.82±0.35† 79.1±12.2 7.14±3.2† 335±25 1.49±0.93* 1.37±0.85* 
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Normalized time varying elastance curve. The mean En(tn) for the two groups were 
compared at 10 time intervals over the cardiac cycle and statistical significance found at the 
intervals marked with an asterisk or a cross (Figure 3). Significant differences were found at 
the following points: start of PEP (*p<0.05), the main part of the Ejection period (*p<0.05), 
the end of the IVR phase (*p<0.05) and the complete diastolic period (†p<0.01) (Figure 3).  
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Figure 3. The En(tn) for the CTRL (fine line) and the MI (dark line) groups. Statistical significance of p<0.05 
was observed at the start of the PEP, during the Ejection phase and at the 1,4 time interval. Statistical 
significance of p<0.01 was found during the complete diastolic period. 
 
The slopes of the En(tn) during the pre-ejection period, αiso, were 2.31±0.38 vs 1.84±0.28 for 
the CTRL and MI group, respectively, and are statistically significant (p<0.05) (Figure 4A). 
This suggests a reduced contractility in the early systolic phase in the MI group. The αeje 
compared between the CTRL and the MI group was 0.40±0.17 vs 0.47±0.19, respectively, 
with no evidence of statistical significance (Figure 4B).  
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The τ constant derived from the exponential decay time (е –t/τ) was found to be 8.33±1.70ms 
vs 6.07±1.58msec for the CTRL and the MI group, respectively, the difference being 
statistically significant (p<0.05, Figure 4C). This indicates a quicker relaxation time in the 
CTRL group. 
The normalized Emin for the CTRL and the MI group was 0.05±0.03 and 0.09±0.04, 
respectively, the difference being significant (p<0.05, Figure 4D).  
Beta (β) was found to be 0.15±0.08 and 0.31±0.11 for the CTRL group and the MI group, 
respectively, with p<0.05* (Figure 4E). 
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Figure 4. Comparison made between the CTRL (white) and the MI group (grey) with p<0.05*. Panel A α (iso), 
B α (eje), C 1/τ, D E*min and E Beta (β).  
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Discussion  
 
Main findings 
We have found that the En(tn) although similar in shape, differs quantitatively between normal 
and failing rat hearts, after induced myocardial infarction. Differences in En(tn) were found 
during ejection, isovolumic relaxation and at end diastole (Figure 3). Also, there is a 
difference in the slope of the En(tn) at the PEP (αiso, Figure 4A), in the decay of En(tn)during 
the IVR phase (τ, Figure 4C), and at the ratio of PEP/ET slopes (ß, Figure 4E). The functional 
and dimensional parameters representative of cardiac function are altered due to the MI 
(Table 1).  
The use of time-varying elastance for assessing cardiac function in health and disease 
Cardiac function has here been evaluated using the Conductance catheter (CC)).  The CC was 
first used by Baan in 1980 and has gained popularity as an accepted method to establish 
indices of cardiac contraction in rodent models and derived in the present study and as 
mentioned above [3,7,15]. Suga and colleagues have shown that the TVEC is fairly 
independent of loading conditions, contractile state and heart rate [19] However, subsequent 
studies revealed limitations to this simplified theory, such as ESPVR curvilinearity, afterload 
dependence under certain conditions and that Vo may change during contraction [10,15,18]. 
Further, the ESPVR has been reported to be influenced by regional ischemia in acute and 
chronic animal models of heart failure [6,13] and augmented in spontaneously hypertensive 
rats [2].  
Uniqueness of the normalized time-varying elastance curve 
Senzaki et al. have reported on human data and showed that the shape of the En(tn) is 
independent of different cardiac pathologies, afterload, preload, and contractility [17]. In a 
later study by the same group, Georgakopoulos et al. showed that the shape of the En(tn) is 
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identical in different animal species, the similarity in En(tn)being attributed to small 
differences in myofibril protein isoforms and protein kinetics among species [4]. 
Assuming a unique En(tn), Senzaki et al. advocated the use of such a global En(tn) to derive 
ESPVR values from non-invasive single-beat recordings of ventricular pressures and volumes 
[17]. This could have potentially important clinical implications, because echocardiography 
could be used to estimate ventricular volume and peripheral arterial pressure for 
intraventricular systolic pressure, thereby providing a clinically feasible noninvasive estimate 
of cardiac contractility. Several other groups pursued this technique due to the fact that no 
vena cava occlusion is required and which makes feasible clinical applications [9,11]. A 
number of subsequent studies have shown, however, that the method proposed by Senzaki is 
not accurate or non-applicable. For example, Shisido et al. used a bilinear approximation for 
the time-varying elastance focusing primarily on the shape of the En(tn).  The ratio of the two 
slopes, Beta, supposedly constant in a global En(tn), was found to correlate to EF, Emax and Ea 
[18]. Kjorstad et al. also found the concept of a global En(tn) inaccurate and the single-beat 
based method for deriving ESPVR imprecise and incapable of showing anticipated changes in 
contractility [8]. When scrutinizing Senzaki et al’s results, one reveals large differences 
(standard deviations) on the En(tn), especially during the ejection and diastolic phases in the 
presence of aneurysms, dilated cardiomyopathy and coronary artery diseased (with conserved 
LV function) groups [17].  
A more sensitive comparison of the En(tn) under different conditions and pathologies is 
obtained by looking at variations in the slope (time derivatives) of the En(tn) during different 
phases of the heart cycle (αiso and αeje). Obviously, time derivatives of the En(tn) (dE*/dt) relate 
in a straightforward manner to time derivatives of the pressure (dP/dt) during the isovolumic 
contraction and relaxation phases, but the relation becomes more complex during ejection. 
The slope of En(tn) during the PEP phase (αiso) decreased significantly in MI rats (Figure 4A). 
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In consequence, β rose in the MI group (Figure 4E). Shisido et al., who found that β was 
significantly attenuated during reduced contractility and vasoconstriction but augmented 
during vasodilatation [18]. Kjorstad et al. showed significant differences in β values between 
controls and postischemic groups. In the same study, during the administration of 
methoxamine, to augment afterload, the En(tn) was altered in shape especially during the ET 
and diastolic phases which we also found in the MI group (Figure 4) [18].  Hayashi et al used 
β and found the ratio Ees/Ea, proposed by Sunagawa, to correlate significantly and positively 
under various contractile and loading conditions [5,20]. The ratio Ea/Ees in our study was 
effectively >1 for the MI group (1.36±0.73) and < 1 for the Co group (0.92±0.36) though not 
statistically significant when compared between the two groups.  
Validation of the MI-induced HF model 
We have based our study on the En(tn) on a comparison between a CTRL and a MI-induced 
failing heart model. A number of parameters relating to cardiac geometry, systolic and 
diastolic function were measured to validate our heart failure model and similar geometrical 
findings were presented using MRI in a study by Nahrendorf et al. [12]. The failing hearts are 
dilated as seen by the increased Vmin and Vmax values (p<0.05 and 0.01 respectively, Table 1). 
SV is compromised while HR is maintained resulting in reduced CO, decreased EF, SV and 
PRSW also representative in our HF model (Table 1). In addition, there are changes in the 
diastolic portion of the pressure-volume relationship, namely an elevated EDP (Table 1), 
indicating the presence of combined systolic and diastolic heart failure [21].  
dP/dtmax is compromised during HF which we advocate though not statistically significantly 
(Table 1). Nevertheless, when dP/dtmax–EDV is compared, a significant difference is 
established (Table 1).  
PRSW is sensitive to contractility changes, such as those induced by MI, but insensitive to 
preload and afterload alterations. Thus, PRSW when compared to Emax, is more sensitive to 
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inotropic state, remains linear under most conditions and is independent of HR. When 
comparing the CTRL and MI groups, Emax was comparable but PRSW showed a significant 
difference with p<0.01 (Table 1). The HF model is also validated by a compromised 
contraction time and contractility index (Table 1). 
During diastole, E*min was significantly greater in the MI group (Figure 4D) and therefore 
EDP rises as the ventricle goes into failure (p<0.01 and Table 1). Tau, the index of time 
constant of isovolumic LV pressure decline being an indicator of diastolic function is 
prolonged during MI (Table 1, p<0.05*) and advocated with our exponential decay time seen 
in Figure 4C. Tau and relaxation time are also significantly prolonged which supports the 
diastolic HF model (p<0.01, Table 1). 
In conclusion, in our model of MI, cardiac function is compromised. The overall features of 
the En(tn) are qualitatively comparable between the CTRL and MI groups, however, when 
En(tn) is compared quantitatively between the two groups, statistical significance is found at 
the ejection phase and during diastole. Also, there is a difference in the slope of the En(tn) at 
the PEP (αiso ), at the IVR phase (τ), and at the ratio of PEP/ET slopes (β). These differences 
need to be taken into account when assessing cardiac contractility based on a generalized 
TVEC in different animal models or in the human in different physiological or pathological 
states.  
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Abstract 
 
The rodent model of myocardial infarction (MI) is extensively used in heart failure (HF) 
studies. However, long term follow-up of echocardiographic left ventricular (LV) function 
parameters such as the myocardial performance index (MPI) and its ratio with the fractional 
shortening (LVFS/MPI), has not been validated in conjunction with invasive indices, such as 
those derived from the conductance catheter (CC).  
Sprague-Dawley rats with LAD coronary artery ligation (MI group, n=9) were compared to a 
sham operated control group (CTRL group, n=10) without MI. TTE was performed every 2 
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weeks over an 8 week period, after which classical TTE parameters, specially MPI and 
LVFS/MPI were compared to invasive indexes obtained using a CC. 
Serial TTE data showed significant alterations in the majority of the noninvasive functional 
and structural parameters (classic and novel) studied in the presence of MI. Both MPI and 
LVFS/MPI significantly (all reported values p<0.05) correlated with body weight (r=-0.58 
and 0.76 for MPI and LVFS/MPI, respectively), preload recruitable stroke work (r=-0.61 and 
0.63), LV end-diastolic pressure (LVEDP) (r=0.82 and -0.80), end-diastolic volume (r=0.61 
and -0.58) and end-systolic volume (r=0.46 and -0.48). Forward stepwise linear regression 
analysis revealed that, of all variables tested, LVEDP was the only independent determinant 
of MPI (r=0.84) and LVFS/MPI (r=0.83). 
We conclude that MPI and LVFS/MPI correlate strongly and better, than the classic 
noninvasive TTE parameters, with established invasively assessed indexes of contractility, 
preload and volumetry. These findings support the use of these two new noninvasive indexes 
for long-term analysis of the post-MI LV remodeling. 
Keywords: echocardiography, heart failure, hemodynamics, infarction, ventricular function 
 
 
Introduction 
 
The understanding of the progressive structural and molecular cardiac changes 
following myocardial infarction (MI) is of major interest to the cardiovascular research 
community [11,24]. It may indeed contribute to the development of new therapeutic 
modalities for heart failure (HF) [17]. The changes in cardiac structure and function in the 
follow-up of MI can be assessed using different techniques, including both invasive 
(conductance catheter, CC) and non-invasive approaches (tran thoracic echocardiography, 
TTE) [2,27]. Among other advantages, the non-invasive echocardiographic methodologies are 
certainly appealing for long term follow-up protocols. In addition TTE is an established 
clinical diagnostic tool [22].  
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Several structural and functional parameters can be assessed using TTE such as 
myocardial wall thickness, end systolic and diastolic volumes, left ventricular (LV) mass, 
ejection fraction (EF), fractional shortening and velocity of circumferential fibre shortening. 
The myocardial performance index (MPI) is a relatively recent parameter combining both 
systolic and diastolic functions. MPI is the ratio of total time spent in isovolumic activity 
(isovolumic contraction and relaxation times) to the ejection time and is measured from the 
mitral inflow and LV outflow time intervals. Recently, in a clinical setting, the MPI has been 
described as a predictor of cardiovascular mortality, independent of other measurements of 
cardiac function (EF, wall motion score index) and of traditional cardiovascular risk factors 
(smoking, diabetes, hyperlipidemia and hypertension) in elderly men [1]. Additionally, it 
correlates to plasma Brain Natriuretic Peptide (BNP) in patients with hypertrophic 
cardiomyopathy [15]. It is an attractive parameter as it appears to be independent of the LV 
shape. Indeed, the measurement of the LV dimensions is not mandatory. It has been reported 
that MPI correlates with dP/dtmax and tau and is affected by the pre- and afterloads 
[3,13,14,29]. However, the MPI’s preload-dependency reported by Moller et al. in patients 
without MI [13] could not be reproduced by Cheung et al. in a porcine model [6]. 
Nevertheless, its reliability has been proven clinically [18,19] as well as in large [12] and in 
small animal models of MI [14]. Furthermore, despite its increasing use, MPI has never been 
validated against established indices of systolic and diastolic function as assessed from 
pressure-volume data in chronic rodent models of MI. Only volumetric comparisons were 
reported [5,8] and only one study correlated MPI with certain CC parameters in a porcine 
model [12]. In a clinical setting, compared to other TTE parameters such as EF and E/A ratio 
(peak early diastolic filling velocity over peak filling velocity at atrial contraction), the MPI 
appears more representative and sensitive to functional changes provoked post MI [18,19]. 
Therefore, we thought it would be instructive to analyze in a follow-up study the possible 
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interest of this parameter to capture the LV structural and functional alterations occurring 
during the post-MI remodeling period.  
Also, because the LV fractional shortening (LVFS) is an ejection phase index [3], we 
hypothesized that the ratio of these two parameters (LVFS/MPI) would be more sensitive to 
MI induced alterations of cardiac function as compared to MPI alone. Therefore, the aim of 
this study was to assess changes in MPI and the LVFS/MPI ratio in a rodent MI model and to 
correlate MPI as well as the related LVFS/MPI index to other invasive indices obtained by 
CC. 
 
Material and methods 
Animals. Male Sprague-Dawley rats were purchased from Charles River Breeding 
Laboratories (Lyon, France). They were maintained in temperature and humidity controlled 
rooms with typical light-dark cycle and given standard chow and tap water ad libitum. The 
investigation conforms to Guide for the Care and Use of Laboratory Animals published by the 
US National Institutes of Health (NIH Publication No. 85-23, revised 1996).   
Experimental protocol. The rats in the MI group (n=9) had a body weight of 254±19g 
(mean ± standard deviation) and were anesthetized with Isofluorane (Forene, Abbott AG, 
Baar, Switzerland), intubated and ventilated with 100% oxygen at 60 cycles per minute with a 
tidal volume of 2ml (Harvard Apparatus Inc model 683, Holliston, Ma, USA) before the 
surgical procedure was performed. The rats were placed on a heating pad to maintain body 
temperature and disinfection was performed of the thorax. A left thoracotomy was performed 
at the 3rd intercostal space to gain access to the heart. The pericardium was opened and the left 
anterior descending coronary artery was located (between the left atrium and the pulmonary 
artery) and ligated with a 4.0 Polypropylene suture (Ethicon Somerville, NJ, USA) to provoke 
the MI, which was visually confirmed by a change of color of the left ventricle (LV) from red 
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to a purplish/grey distal to the ligation site. The ribs were closed with 2-3 ligatures, a chest 
drain inserted to avoid any pneumothorax and the muscles surrounding the rib cage were 
sutured together before the skin was closed. Analgesia was given (Pro-Dafalgan) in order to 
attenuate any pain ensued by the rodents due to the MI (Upsamedica SA, Baar, Switzerland). 
The anesthesia was gradually weaned and when the rat began to awaken and spontaneous 
breathing resumed, the intubation tube was removed. The rats were then returned to the 
animal house once complete recovery was observed. A sham operation was performed on a 
similar control group (CTRL) (n=10) with the rodents weighing 238±7g (mean ± standard 
deviation). 
Invasive cardiac measurements with the conductance catheter. Eight weeks after the 
initial operation the rats were again anaesthetized and intubated. The right neck region was 
disinfected to provide access to the carotid artery. The skin was opened and the right jugular 
vein and carotid artery were isolated. A 2Fr conductance catheter (SPR 838 Aria®, Millar 
Instruments Inc, Texas, USA) was inserted into the left ventricle via the right carotid artery. 
Parallel conductance was measured after injection of 10% saline into the jugular vein using a 
1ml syringe (20µL Natrium chloratum, Sintetica SA, Mendrisio, Switzerland) in accordance 
to the method by Baan et al. [2]. An occlusion analysis was performed by temporarily 
occluding the inferior vena cava below the diaphragm via a mini laparotomy. For each 
animal, the CC calibration correction factor alpha was assessed with the use of an ultrasonic 
flowmeter (Transonic, Ithaca NY, USA) placed around the ascending aorta.  
From the simultaneous measurement of LV pressure and volume during steady state 
conditions, the following parameters were derived: Stroke Volume (SVc), end-systolic volume 
(ESVc), end-diastolic volume (EDVc), ejection fraction (EFc = SVc/EDVc), isovolumetric 
contraction time (ICT, duration of the isovolumic contraction), peak positive (dP/dtmax) and 
peak negative (dP/dtmin) value of the time-derivative of LV pressure, contractility index 
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(dP/dtmax divided by the pressure at this point), isovolumetric relaxation time (IRT, duration 
of the isovolumic relaxation), time constant of relaxation derived from the peak systolic 
pressure to the next begin of diastolic pressure (Tau), heart rate (HR), left ventricular end-
diastolic (LVEDP) and begin diastolic pressures (LVBDP), taken as the pressures associated 
with the bottom left and right corner of the pressure-volume loop, respectively, systolic 
(LVSP) and end-systolic pressure (LVESP), systolic ejection period (SEP) and diastolic 
filling period (DFP). Cardiac output (COc) was calculated from HR multiplied by SVc. The 
subscript ‘c’ refers to data measured with the conductance catheter in order to differentiate 
between the same parameters measured with TTE.  
From the occlusion data, we calculated the slope (Ees) and volume axis intercept (V0) 
of the end-systolic pressure-volume relationship (ESPVR), the slope of the end-diastolic 
pressure-volume relationship (EDPVR), preload-recruitable stroke work (PRSW) (with stroke 
work assessed from the area enclosed by the pressure-volume loop), preload adjusted dP/dtmax 
(slope of the relation between dP/dtmax and end diastolic volume (EDVc)).  
Echocardiographic measurements. TTE was performed at baseline and every two 
weeks for an eight week period with a commercially available echocardiographic system 
(C256 Sequoia, Acuson, Mountain View, CA, USA) with the animal in the left lateral 
decubitus position. Light anesthesia was used during the analysis with Isofluorane ventilated 
inside a nose-cone at 0.5l/min with 100% oxygen (Forene, Abbott AG, Baar, Switzerland). 
Once asleep, the rat was shaven with an electrical razor (Surgical clipper 9661, 3M health 
care, MN, USA). Ultrasound transonic blue gel (Tyco healthcare/Kendall, Mallinckrodt Dar, 
MO, Italy) was placed on the thorax to optimize visibility of the cardiac chambers. A 15MHz 
linear array transducer (15L8) was used with a frame rate of 100Hz using bidimensional and 
color Doppler imaging. The probe was placed to obtain short and long axis and four chamber 
views. From the long axis view, an M-mode trace of the LV was obtained, and LV end-
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diastolic diameter (LVDed), LV systolic diameter (LVDes), and posterior and septal wall 
diastolic wall thickness (PWth and SWth) were measured. LV fractional shortening (LVFS) 
was calculated according to = (LVDed-LVDes)/LVDed x100. Ejection fraction was 
calculated from a long axis view using planimetry (EFe) = 100*(LVDed3 –LVDes3 )/LVDed3. 
Velocity of circumferential fiber shortening (Vcf) was calculated using the following formula 
(LVDed-LVDes)/(ET x LVDed). The subscript ‘e’ refers to data assessed with 
echocardiography. End diastolic volume (EDVe) and end systolic volume (ESVe) were 
calculated using the Simpson’s method, and stroke volume SVe was calculated as EDVe-
ESVe. Aortic flow or cardiac output (COe) was recorded and calculated using pulse Doppler 
imaging, with the smallest possible sample volume placed at the level of the aortic annulus. 
Doppler yields the velocity profile (aortic velocity time integral (VTI)) which is multiplied 
with the cross sectional area of the outflow tract to obtain flow. Integration of the velocity 
profile yields the aortic velocity time integral. LV mass was calculated as = 
(((LVDed+SWth+PWth)3 –LVDed3)*1.04)*0.8+0.14 (in grams, with LV dimensions 
expressed in mm)  [20]. Relative wall thickness was assessed as RWT = 
(PWth+SWth)/(LVDed). LV ejection time (ET) was measured as the time from the beginning 
to the end of the aortic flow wave (Figure 1). Isovolumic relaxation time (IRT) was measured 
as the interval between the aortic closure click and the start of mitral flow, while isovolumic 
contraction time (ICT) was obtained as the time delay between the cessation of mitral inflow 
and the onset of aortic ejection. Additionally, the mitral valve closure time (MCO) was 
measured. MPI is then defined as (MCO-ET)/ET = (ICT+IRT)/ET (Figure 1). A newer index 
of LV function, proposed by Broberg et al., LVFS/MPI, was also assessed [3]. 
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A   B     C
 
 
 
 
 
 
 
Figure 1. Panel A shows schematic representation of mitral inflow and left ventricular (LV) outflow obtained from pulsed-wave Doppler and used to calculate the myocardial 
performance index whose formula is shown on the top of Panel A. ICT, isovolumic contraction time; IRT, isovolumic relaxation time; ET, ejection time; MCO, time from 
closure until opening of the mitral valve; a, the sum of the isovolumic contraction time, ejection time, and isovolumic relaxation time; b, ejection time. Panels B and C show 
typical transmitral flow images in control (B) and MI (C).  
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Statistical analysis. TTE was performed three times on each rat and measurements 
were averaged. Values are reported as means ± SD. Echocardiographic follow-up data were 
analyzed using a general linear model of repeated measurements ANOVA, with time as 
within-subjects factor, and group (MI or control) as between subject’s factor. At each instant 
in time, values were considered different between groups if statistical significance reached 
p<0.05. If the ANOVA test indicated an effect of time within one of the groups, paired t-tests 
were performed, with baseline data as fixed control. P-values <0.05 were considered 
significant. The MPI and LVFS/MPI were correlated with TTE and the CC measurements of 
LV systolic and diastolic function using a Pearson product moment correlation, in as much as 
data were normally distributed, with relations considered significant when reaching *p<0.05. 
Correlations were performed with the pooled data and then with the two groups separated. 
Forward stepwise regression analysis was performed for MPI and LVFS/MPI (dependent 
variable) with all aforementioned conductance catheter and TTE derived parameters as 
independent variables. All analysis was done in SPSS (SPSS 11.5, SPSS Inc, Chicago, IL, 
USA). A Bland-Altman analysis was performed between the CC and TTE data for SV, ESV, 
EDV, EF and MPI, using the data measured at week 8, to compare the compatibility in 
ventricular volumes as measured by the noninvasive (TTE) and invasive (CC) techniques.   
 
Results 
 
Hemodynamics assessed with the Conductance Catheter (volumetric data with 
subscript c). ESVc and EDVc rose significantly in the MI group as compared to the CTRL 
group. V0 also increased significantly. The evolution of the heart failure caused the LVEDP to 
rise significantly (Table 1).  
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Table 1. Comparison between the two groups for different invasive indices analyzed at sacrifice with the 
conductance catheter. Ejection fraction (EFc), preload recruitable stroke work (PRSW), left ventricular end-
diastolic pressure (LVEDP), left ventricular begin diastolic pressure (LVBDP), volume axis intercept (V0), 
isovolumic relaxation time (IRT), isovolumic contraction time (ICT), contractility index (CI), left ventricular 
end-systolic pressure (LVESP), end systolic elastance normalized to LV mass (E*es LV mass) and cardiac output 
(COc). See Figure 3 legends for other abbreviations. *p<0.05, †p<0.01 CTRL vs MI at same age. 
 
 Parameters Control Group MI Group 
EDVc (ml) 0.52±0.10 0.75±0.15* 
ESVc (ml) 0.15±0.07 0.56±0.14* 
SVc (ml) 0.35±0.07 0.25±0.05 
V0  (mL) 0.155±0.039 0.254±0.092* 
LVESP (mmHg) 90±20 93±16 
LVEDP (mmHg) 5.7±2.1 9.8±1.9† LV
 p
re
ss
ur
es
 a
nd
 v
ol
um
es
 
LVBDP (mmHg) 6.4±14.2 8.6±4.9 
dP/dtmax (mmHg/ms) 5128±1241 4606±1407 
dP/dtmax  -  EDVc (mmHg/s/µL) 25.8±11.2 20.5±7.0* 
CI (s-1) 95.7±6.7 76.3±11.6* 
Is
ov
ol
um
ic
 c
on
tra
ct
io
n 
ph
as
e 
in
di
ce
s 
ICT (ms) 17.6±2.4 20.2±1.8* 
E*es LV mass (mmHg/(µL/g)) 0.85±0.19 1.10±0.24* 
C
on
tra
ct
ile
 
in
di
ce
s 
PRSW (mmHg) 69.8±17.2 50.1±16.6* 
EFc (%) 54.2±15.4 36.1±14.3* 
Ej
ec
tio
n 
ph
as
e 
in
di
ce
s 
COc (ml/min) 108±45 72±33* 
Tau (ms) 12.2±11.3 17.3±6.8* 
dP/dtmin (mmHg/ms) -4722±475 -4406±1200 
A
ct
iv
e 
ph
as
e 
of
 
re
la
xa
tio
n 
in
di
ce
s 
IRT (ms) 46.4±4.7 53.6±5.1* 
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The dP/dtmax, dP/dtmax-EDVc, contractility index and contraction time were all altered in the 
MI group. The slope of the ESPVR, Ees, was similar in both groups, though the ESPVR in the 
MI group did shift notably to the right thus raising the V0 values. However, Ees normalized to 
LV mass decreased in the MI group. Also, the PRSW and SVc were compromised in the MI 
group. EFc and COc decreased significantly in the MI group (Table 1). Tau increased in the 
MI group. The IRT was significantly prolonged in the MI group. dP/dtmin was augmented by 
10% in the MI group (p=NS, Table 1). 
Echocardiography (volumetric data with subscript e) and serial follow-up data.  
Body weight increased with age in both groups but remained significantly lower in the MI 
group (Figure 2A). LV mass increased with age in both groups however, after 8 weeks 
absolute LV mass was higher in the MI group (0.98±0.11g (CTRL) vs 1.29±0.10g (MI), 
p<0.01). The same applied for LV weight/body weight ratio being 1.70±0.20g/kg (CTRL) vs 
2.45±0.45g/kg (MI) (p<0.01). The HR was comparable between the CTRL and MI groups 
being 318±29 beats/min and 319±29 beats/min, respectively, at week 8.  
The EFe was comparable at baseline but decreased significantly in the MI group (Figure 2H). 
The DVe and ESVe were significantly greater in the MI group versus the CTRL group (Figure 
2B, C). The SVe decreased significantly in the MI group (Figure 3D).  
RWT and LVFS attenuated in the MI group but remained stable in the CTRL group (Figure 
2E, ). Vcf rose slightly in the CTRL group but was conserved in the MI group (Figure 2G). 
COe was significantly less in the MI group (p<0.05) at week 8 (89±14ml/min (MI) vs 
112±20ml/min (CTRL)).  
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Figure 2. Echocardiographic measurements from baseline (BL) to week (W) eight with ■ = MI and □ = control. 
Panel A: Body weight (BW, Panel A), End-diastolic volume (EDVe, Panel B), end-systolic volume (ESVe, Panel 
C), stroke volume (SVe, Panel D), Relative wall thickness (RWT, Panel E), Left ventricular fractional shortening 
(LVFS in %, Panel F), Velocity of circumferential fibre shortening (Vcf in s-1, Panel G:), Ejection fraction (EF in 
%, Panel H), Myocardial performance index (MPI, Panel I:), LVFS/MPI (Panel J). Statistical significance 
expressed as *p<0.05 and **p<0.001. 
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MPI and valve opening and closure timing parameters. The ICT was stable in the 
CTRL group but was prolonged in the MI group. The IRT was not different between groups 
but did rise in the MI group when compared to baseline at week 6 and 8 (p<0.001). ET 
remained stable over time without any relevant difference between the groups. Consequently, 
the MPI increased significantly in the MI group when compared to the CTRL group (Figure 
2I). LVFS/MPI decreased significantly in the MI group as compared to the CTRL group 
(Figure 2J).  
Correlation of invasive parameters versus MPI and LVFS/MPI (pooled data). In the 
univariate correlation analysis, both MPI and LVFS/MPI were significantly correlated with 
body weight, LVEDP, PRSW, EDV and ESV (Table 2).  
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Table 2. Correlation coefficients (r) and statistical significance (expressed as *p<0.05 and †p<0.01) of MPI, LVFS/MPI, LVFS, EF, Vcf and RWT versus CC parameters for 
the combined groups using univariate regression analysis. See Figure 2 and Table 1 legends for abbreviations.  
 
 
 
 
 
 
 
 
 
 
 
 
  TTE Parameters 
  MPI  LVFS/MPI   LVFS EF Vcf RWT 
        Body Weight  -0.58† 0.76† 0.82† 0.79† 0.86† 0.54*
PRSW       -0.61† 0.63† 0.54* 0.58* 0.58*
LVEDP        0.82† -0.80† -0.68† -0.67* -0.46* -0.78†
EDV       0.61† -0.58† -0.55* -0.64* -0.62*
 
 
 
CC 
parameters 
ESV       0.46* -0.48* -0.58* -0.70† -0.76†
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Forward stepwise linear regression analysis revealed that, of all the variables tested, 
LVEDP was the only independent determinant of MPI (R2=0.70, p<0.0001) and of 
LVFS/MPI (R2=0.68, p<0.0001).  
Correlation of invasive parameters versus MPI and LVFS/MPI (groups separated). 
From the above pooled data, the two groups were separated and univariate regression analysis 
was applied. The corresponding graphs, with the linear regressions and correlation 
coefficients are shown in Figure 3. For the majority of the parameters, the regression lines of 
the pooled data and of the separated groups are almost identical or similar. Overall, the 
correlation coefficients based on the pooled data were comparable to those derived from the 
separate groups (Figure 3 and Table 2). 
Invasive versus non-invasive assessment of ventricular volume, MPI and EF (Bland-
Altman analysis). The average difference found for the EDV was 0.03±0.05ml (Figure 4 A), 
for ESV was -0.04±0.03ml (Figure 4 B), for SV was 0.003±0.02ml (Figure 4 C), for EF was 
5.8±5.4% (Figure 4 D) and for MPI was 0.007±0.02 (Figure 4E). The correlation coefficients 
for ESV, EDV, SV, EF and MPI when absolute values were compared between TTE and CC 
were found to be 0.92, 0.98, 0.92, 0.95, and 0.85 respectively (all p<0.05). The mean alpha 
value used for the volume correction was 2.5±0.8.   
  Intra- and interobserver variability. Intra- and interobserver differences were 5.1±2.1% and 4.4±7.7% 
for LVFS, 6.5±5.8% and 5.8±7.7% for EF, 6.8±3.6% and 6.8±8.8% for Vcf, and 9.6±1.9% and 7.0±5.0% for 
MPI, respectively.  
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Figure 3. Correlation coefficients (R2) of CC parameters versus MPI, LVFS/MPI for the CTRL and MI  groups 
using univariate regression analysis. See Figure 2 and Table 1 legends for abbreviations.  
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Figure 4. Bland-Altman analysis of EDV (A), ESV (B), SV (C), EF (D) and MPI (E), measured by TTE and CC 
at week 8 for the control and MI groups. CTRL rats represented by black triangles and MI rats by black squares. 
The y-axis presents the differences between the two measuring techniques. The x-axis represents the mean values 
of the two measuring techniques. Dashed lines indicate mean differences; dotted lines indicate boundaries of two 
standard deviations of the differences.  
 
 
Discussion 
We evaluated the adaptation response and long term effects of MI on cardiac function 
using TTE in rodents and after 8 weeks compared these data with invasively measured indices 
 
      
of ventricular function. A number of classic and newly proposed parameters (MPI and 
LVFS/MPI) derived noninvasively from TTE were computed and reported. These changes 
post MI were profound and easily detectable by the different noninvasive indices, including 
the two newly proposed ones. More so, significant correlations were established between the 
new and classic noninvasive and established invasive parameters (PRSW, LVEDP, EDV and 
ESV) of ventricular function. The best and most significant correlation coefficients were 
established between the two new parameters and PRSW and LVEDP. EDV expressed similar 
correlation coefficients compared to the classic TTE parameters while ESV showed the 
lowest correlation, however still significant. Therefore, MPI and LVFS/MPI reflect well the 
changes post MI in contractility (PRSW), preload (LVEDP) and volumetry (EDV, ESV).  
Serial assessment of cardiac function. Classically, EF, RWT, LVFS and Vcf are used 
to evaluate systolic function with TTE in rat models of pressure and volume overload 
[4,10,26]. In a rodent study with MI by Sjaarstad et al., body weight, LVFS, Vcf and CO were 
all compromised due to MI [24]. Gao et al. performed TTE in mice, demonstrating that the 
LVFS remains constant over time in control mice but attenuates with time in a model of MI 
[9]. In our study, all of the above parameters and MPI and LVFS/MPI were significantly 
compromised over time due to the MI (Figure 2A, F and G). However, some of the above 
parameters have certain limitations; LVFS and Vcf are preload and afterload dependent and 
are limited by spatial resolution; while EF is frame rate dependent and assumes symmetrical 
contraction, which is not the case in aneurysmal and MI hearts. RWT is only useful in studies 
measuring myocardial wall adaptations due to hypertensive response [10]. If used in MI 
models with an apical infarction present, but M-mode measured at the papillary muscle level, 
values will be falsely positive as the MI would cause wall thinning at the apex. However, in 
our study all MI’s were antero-apical precluding this phenomenon. Therefore, the MPI and 
recently LVFS/MPI [3], were introduced as they have been reported to be independent of load 
 
      
and LV geometry [3,29]. Slama and Salemi et al. have reported the MPI in conjunction with 
serial studies, but only in hypertensive models [23,26]. In our study, these two novel 
parameters fair well compared to the classic TTE parameters reported above (Figure 2). More 
so, the LVFS/MPI seems to visually express alterations in cardiac function post MI more 
clearly, compared to the classic ones, in spite of the large standard deviations (Figure 2J). 
These deviations are as a result of the fact that the infarct size in the MI model is difficult to 
homogenize and vary between 37±7%, not forgetting the variations of intra and inter observer 
variability. Also, it should be acknowledged that MPI is highly dependent on timing intervals 
and temporal resolution and hence susceptible to interpretation errors in cases when heart rate 
changes over time during the experimental procedure.  
Noninvasive versus invasive assessment of cardiac function. We measured cardiac 
function using both TTE echocardiography and CC in the same animal, allowing us to 
correlate findings from both techniques. Hence, the relation between classic (EF, LVFS, Vcf 
and RWT) and novel indices such as MPI and LVFS/MPI, and established invasive cardiac 
function parameters, could be derived (Table 2). The MPI and LVFS/MPI express the largest 
correlation coefficients and most significant for PRSW and LVEDP compared to the classic 
ones. Similar coefficient values are found between classic and novel indices with respect to 
EDV. However, ESV shows the smallest relationship for the novel indices, none the less still 
significantly comparable. LVFS correlated well to the invasive indices but not as well as MPI 
and LVFS/MPI (Table 2). LVFS has also been shown to be related to dP/dtmax (and is 
modified with contractility and afterload manipulations) [3,16] and dP/dtmin  [9]. Therefore, 
LVFS could be considered as a good marker to represent serial and endpoint cardiac function. 
However, Vcf has been shown to be dependent on dP/dtmax and is modified with contractility, 
preload and afterload manipulations [3]. In our study, Vcf could not correlate to invasive 
indices except for LVEDP.  
 
      
Concerning the MPI, it has been reported that the MPI correlates with dP/dtmax, 
dP/dtmin, LVEDP and tau and that it is dependent on contractility yet also affected by preload 
and afterload [3,14,25]. The dependence of MPI on preload was also reported by Moller et al. 
in patients without MI [13]. However, in a recent publication by Cheung et al., this 
phenomenon could not be reproduced in a porcine model [6]. In our study, MPI correlated 
with PRSW, a measure of contractility, and with LVEDP and LV volumes. Tei et al. also 
found correlations of MPI with dP/dtmax and tau when using cardiac catheterization in larger 
mammals [29], but we could not confirm this finding using our data. In an acute MI setting, 
Morgan et al. also showed the MPI to correlate to end-systolic and end-diastolic TTE 
dimensional values [14]. We advocate this by expressing a relationship between MPI and 
ESV and EDV (Table 2). Furthermore, it must be stipulated that the MPI is LV geometry 
independent, thus ideal for studying the course of a disease associated with chamber 
remodeling, typically elaborated during MI [29].  
Concerning the LVFS/MPI, it was shown by Broberg et al. that this ratio correlated 
strongly with dP/dtmax in mice and was dependent on contractility and afterload variations, but 
not on preload variations [3]. However, in our study, the above ratio correlated to the load-
independent contractile parameter PRSW, to LVEDP (preload) and volumetric ones (Table 2) 
but not to dP/dtmax. Therefore, the ratio is also affected by preload as LVEDP varies with MI. 
In our study of chronic MI, LVFS/MPI was the most sensitive to changes in contractility 
(PRSW) and filling (LVEDP) compared to classic TTE parameters. In multiple linear 
regression analysis, LVEDP appeared as the strongest predictor of MPI and LVFS/MPI, 
suggesting that these indices are potentially useful non-invasive indicators of filling pressure 
in the rat, at least in the setting of cardiac remodeling following MI. 
It is to be emphasized that the reported data was obtained in a pooled analysis, 
including both control and MI data. When comparing EDV, ESV, EF, MPI and SV as 
 
      
assessed by CC with TTE using the Bland-Altman analysis, the mean difference is close to 
zero for all parameters validating the coherence of the two methods. Slight discrepancies exist 
between the two methods, as the TTE accuracy is frame rate dependent and the CC accuracy 
depends on initial calibration, alpha estimation and the calculation of parallel conductance [8]. 
With this in mind, both methods are representative and suitable for evaluating changes in 
cardiac function. EFc correlates well to EFe (r=0.80 with p<0.01) and the differences in EF 
that are visible between the two groups are similar between the two methods (bias 6%) as 
seen in Table 1 and Figure 4 respectively. Similar correlations between CC and TTE have 
been demonstrated as the ones we found for ESV and EDV [5]. Also, MPIe has been 
correlated to MPIc with a bias of only 0.007 (roughly 2%). Due to the fact that at week 8, 
acceptable concordance was achieved between methods, one can assume that during the time 
course of the study, similar relations can be established. Thus, validating not just endpoints, 
but also the cardiac structural (EDV, ESV, SV) and functional (EF, MPI) variations from the 
study’s baseline.  
Study limitations. The number of animals in each of the subgroups was comparable to other 
studies, justifying detailed analysis of the MPI and LVFS/MPI within each subgroup. When 
compared to other research groups, between 6 and 12 rats are used per group [7,9,26] and all 
correlations are performed by pooling the analyzed data [14,25]. Therefore, after a detailed 
literature review, no other group has demonstrated acceptable correlations using subgroup 
analysis techniques. Another limitation arises from the use of anesthetics which might 
influence the data due to its effect on inotropy and chronotropy. However, following previous 
reports, we used Isoflurane during the complete study period as it seems to be the most 
appropriate technique for repeated and prolonged studies necessitating stable haemodynamic 
conditions [21]. In addition, the simultaneous measurement of the TTE and CC parameters is 
technically challenging as the rat is small and the positioning of the TTE probe in performed 
 
      
with the animal in the lateral decubitus position.  
In conclusion, we were able to follow serial changes in cardiac function post MI with 
these novel parameters (MPI or LVFS/MPI) with success and as efficiently as classic TTE 
parameters. More so, LVFS/MPI visually expressed better the serial modifications in cardiac 
function. Both novel parameters were correlated to the load-independent contractile 
parameter, PRSW, and to the preload parameter, LVEDP, being pertinent in following 
preload changes post MI. Finally, chamber remodeling post MI can successfully be followed 
due to the fact that ESV and EDV both correlate to MPI and LVFS/MPI    
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Abstract 
 
Objective: Rodent models of isolated systolic hypertension (ISH) are rare. One exception is 
the vitamin D3 and nicotine (VDN) model, in which arterial calcification raises arterial 
stiffness and vascular impedance. Although several aspects of the effects of VDN treatment 
on arterial or cardiac hemodynamics have been investigated, a complete analysis of the effect 
of VDN on ventricular-arterial interaction has not yet been performed. 
Methods: Wistar rats were treated with VDN (VDN group, n=9) and a control group (CTRL, 
n=10) was included without the VDN treatment. At week 8, invasive indexes of cardiac 
function were obtained using a conductance catheter. At the same time, aortic pressure and 
flow were measured to derive vascular impedance and characterize ventricular-vascular 
interaction.  
Results: VDN caused significant increases in systolic (138±6 mmHg vs. 116±13 mmHg, 
p<0.01; mean ± stdev) and pulse pressures (42±10 mmHg vs. 26±4 mmHg, p<0.01) with 
respect to control, whereas diastolic pressure, stroke volume and cardiac output remained 
unaltered. Total arterial compliance decreased (0.12±0.08 ml/mmHg vs. 0.21±0.04 ml/mmHg 
in control, p<0.05) and pulse wave velocity increased significantly (8.8±2.5 m/s vs. 5.1±2.0 
m/s in control, p<0.05). The arterial elastance rose significantly in the VDN group (p<0.05). 
Preload recruitable stroke work and end-systolic elastance were both elevated in the VDN 
group thus decreasing the ratio of arterial elastance over end-systolic elastance and 
augmenting efficiency. Wave reflection was augmented in the VDN group, as reflected by the 
increase in the wave reflection coefficient, Γ (0.63±0.06 vs. 0.52±0.05 in control, p<0.05), 
and the amplitude of the reflected pressure wave (13.3±3.1 mmHg vs. 8.4±1.0 mmHg in 
control, p<0.05).  
Conclusions: We studied ventricular-arterial coupling in a VDN-induced rat model of reduced 
arterial compliance. The VDN treatment lead to development of ISH and provoked alterations 
 
      
in cardiac function, arterial impedance, arterial function and ventricular-arterial interaction, 
which in many aspects are similar to effects of an aged and stiffened arterial tree. The VDN 
model may thus prove to be a useful model to study the patho-physiological effects of 
increased arterial stiffness.  
 
Keywords: blood flow, calcium, hypertension, hemodynamics, ventricular function.  
 
Introduction 
 
Epidemiological studies have emphasized the close relationship between elevated 
blood pressure and the incidence of cardiovascular disease [44]. Systolic blood pressure and 
pulse pressure (PP), in particular, have been demonstrated to be strong independent predictors 
of cardiovascular mortality [10,33]. PP is on one hand determined by heart-related parameters 
such as heart rate and stroke volume (also related to arterial load), but also by the cushioning 
capacity of arteries (total arterial compliance) and the timing and intensity of wave reflections 
[28,41]. The former is influenced by arterial stiffness, which is usually expressed as the 
inverse of stiffness, i.e., as compliance or distensibility. The latter results from the summation 
of all backward running waves i.e., waves returning towards the heart after reflection at 
peripheral sites. In a recent review, aortic stiffness (measured from aortic pulse wave velocity, 
PWV) and an early return of reflected waves to the heart have been established as 
independent predictors of cardiovascular risk [35].  
During aging, alterations in aortic structure and function occur, leading to a decrease 
in aortic compliance. In particular, the arterial extracellular matrix undergoes many profound 
age-related changes responsible for wall stiffening. Age-dependent medial degeneration, 
including phenomena such as elastocalcinosis (calcification followed by degeneration and 
fragmentation of elastic fibers) is probably the most important element in increased arterial 
stiffness [2]. More than 6 decades ago, Blumenthal et al. have noted that the time course of 
 
      
the decrease of elasticity with age closely paralleled the curve of the intensity of medial 
calcification with age [5]. Another interesting case is provided by patients suffering from end-
stage renal disease, in which aortic pulse wave velocity is related to aortic calcification [23]. 
To study the effects of arterial stiffening on arterial and cardiac function, many 
experimental animal models have been used, ranging from acute animal models where the 
aorta was either replaced by a stiff tube [18,30] or wrapped with a non-compliant Dacron 
band [15], to chronic models, where aortic stiffness is increased by inbreeding [14], as a result 
of hypertension-induced remodeling [16] through some chemical or biological treatment or 
old age [2,7,25]. Of particular importance is a model of aortic elastocalcinosis induced by the 
administration of vitamin D3 and nicotine (VDN), developed originally by Hass et al. [11]. 
The VDN model leads to arterial stiffening by decimation of the arterial wall elastic fibre 
network [29]. Earlier studies on the effects of VDN on arterial hemodynamics showed that 
arterial stiffening caused by VDN decreased compliance and increased wave speed, aortic 
characteristic impedance, and wave reflections leading to isolated systolic hypertension (ISH) 
and the development of compensatory LV hypertrophy [20,21,25].  
To date, however, no data have been reported on the effects of VDN on cardiac 
dimensions using trans-thoracic echocardiography (TTE) and conductance catheter (CC), 
contractility, and on the resulting changes in the interaction between the heart and the vessels 
i.e. ventricular-arterial coupling. The primary goal of this work, therefore, is to assess the 
changes occurring at the arterial and cardiac levels after aortic stiffening with VDN, and 
comprehensively quantify the resulting changes in arterial hemodynamics, cardiac function 
and ventricular-arterial coupling.  
 
Material and methods 
 
Animals. Male Wistar rats were purchased from Charles River Breeding Laboratories 
(Lyon, France). They were maintained in temperature and humidity controlled rooms with a 
 
      
typical light-dark cycle and given standard chow and mineral water (Mont Roucous, France) 
ad libitum. The investigation conforms with the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health (NIH Publication No. 85-23, 
revised 1996).   
Experimental protocol for the VDN treatment. The procedure for preparing the 
calcification model was described previously by Lartaud et al [20]. Briefly, on day 1, 15 rats 
were injected (300 000 IU/kg hind leg muscle) with vitamin D3 (Duphafral D3 1000, Duphar 
BV, Weesp, The Netherlands) at 9AM and given nicotine (Nicotine hydrogen tartrate, Sigma 
Chemical Company, MO, USA) 25mg/kg. Nicotine was given orally by gavaging in 5ml/kg 
sterile water twice, at 9AM and 5PM (vitamin plus nicotine group, VDN). The VDN is a one-
day only treatment. Another 10 rats received an injection with normal saline intramuscularly 
and underwent two gavages of distilled water (control placebo group, CTRL).  
The VDN rats were two months old with a body weight of 226±8g (mean ± standard 
deviation). Four rats died within the first two weeks and two died at week 5 thus leaving n=9. 
The control group had the same age and similar body weight (BW) of 226±7g. No deaths 
occurred. The two groups were housed for an 8 week period and were then sacrificed, after 
analyzing cardiac and vascular function.  
Assessment of arterial structure and function. Aortic flow (Figure 1A) was measured 
using a transit-time ultrasonic flow meter (Transonic, Thaca NY, USA) with the flow probe 
placed around the ascending aorta and filled with conducting gel. Aortic pressure (Figure 1A) 
was measured by retracting the CC from the LV into the ascending aorta. As soon as the trace 
changed from an LV one to an aortic one, the CC was withdrawn 0.5cm in order to ensure 
that the CC and flow meter were positioned on the same spot. From the pressure signal, mean 
arterial pressure (MAP), systolic (SBP), diastolic (DBP) and pulse pressure were derived 
(PP). Steady state measurements containing 10 cycles were averaged to construct a 
 
      
representative steady-state beat of aortic pressure (Pao) and flow (Qao). Discrete Fourier 
transform (Mathematica 5.2®, Wolfram Research Inc., IL, USA), was applied to obtain 
pressure and flow in the frequency domain.   
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Figure 1. Panel A: aortic pressure (black) and flow (grey) measured during steady state conditions. From these, 
input impedance is derived (Panel B) as well as the forward (Pf) and backward (Pb) running pressure wave 
components (Panel E). t is the time interval between the foot of the forward running and the foot of the 
reflected wave; |Pb| is the amplitude of the reflected wave. Panel C: left ventricular pressure (grey) and volume 
(black) as measured by the conductance catheter. Panel D: pressure-volume loops after partial vena cava 
occlusion; Ea, is effective arterial elastance; Ees, end-systolic elastance, slope of the end-systolic pressure-volume 
relation; Vo, the intercept of the end-systolic pressure-volume relation; EDPVR, is end-diastolic pressure-
volume relationship.  
      
 
The ratio of mean Pao and Qao (DC component of Zin) is systemic vascular resistance (R). 
Input impedance being a complex quantity, is expressed in terms of its modulus and phase as 
a function of frequency (Figure 1B). The accuracy of the phase estimations may, however, be 
somewhat compromized by a non-precise co-localization of the pressure and flow 
measurements in the aorta. The characteristic impedance of the aorta, Zc, was estimated as the 
average of the impedance modulus between the 5th and the 10th harmonic. The frequency 
response of the Millar pressure catheter is flat up to 100 Hz, and flow signals with filter cut-
off settings of 100 Hz were used. The frequency contents of the signals are thus high enough 
to allow for computation of the 10th harmonic (approximately 60 Hz) [36]. Because heart rate 
differed from animal to animal, impedance values were averaged per harmonic, with mean 
values and standard deviations of modulus, phase and frequency computed and plotted. Total 
arterial compliance (C) was estimated using the Pulse Pressure Method [40]. Pulse wave 
velocity (PWV) was estimated indirectly from the characteristic impedance and ascending 
aorta dimensions as PWV= Zc*A/ρ, where A=πr2 is the luminal cross-sectional area of the 
ascending aorta measured with echocardiography and ρ  being the density of blood.  
 After euthanasia of the rat, the aorta was excised and a 5mm sample of the descending aorta 
was dehydrated in graded ethanol solutions and embedded in paraffin. Three 20µm thick 
sections were stained with hematoxylin-eosin for measurements of internal diameter (Di) and 
medial thickness (h) (Saisam, Microvision Instruments)[20]. Elastic modulus (EM; 106 
dyne/cm2) was calculated according to the Moens-Korteweg equation: EM =(PWV2 x Di x 
ρ)/h, where PWV (cm/s) is pulse wave velocity and ρ =1.05g/ml (blood density). Wall stress 
(WS; 106 dyne/cm2) was calculated from the Lamé equation: WS= (MAP x 1333 x Di)/2h. 
The ratio h/Di was also calculated.  
 
      
Assessment of cardiac function. Eight weeks after the initial treatment (VDN or 
placebo), the rats were anaesthetized and intubated. The right neck region was disinfected and 
the skin opened. The right jugular vein and right carotid artery were isolated. A 2Fr 
conductance catheter (CC) (SPR 838 Aria®, Millar Instruments Inc, Texas, USA) was 
inserted into the left ventricle via the right carotid artery. Parallel conductance (Vp) was 
measured after injection of 10% saline into the jugular vein using a 1ml syringe (20µL 
Natrium chloratum, Sintetica SA, Mendrisio, Switzerland), in accordance to the method by 
Baan et al. [3]. An occlusion analysis was performed by temporarily occluding the inferior 
vena cava through a small window made in the diaphragm via a mini laparotomy. For each 
animal, the CC calibration factor, α, was assessed as the ratio of stroke volume (SV) over CC-
derived SV. SV was derived from aortic flow, which was measured simultaneously by means 
of an ultrasonic flowmeter (Transonic, Ithaca NY, USA) placed around the ascending aorta.  
From the simultaneous measurement of LV pressure and volume during steady state 
conditions (Figure 1C), the following parameters were derived: Stroke Volume (SV), end-
diastolic volume (EDV), ejection fraction (EF = SV/EDV), peak positive (dP/dtmax) and peak 
negative (dP/dtmin) value of the time-derivative of LV pressure, heart rate (HR), left 
ventricular end-diastolic (LVEDP) and end-systolic pressure (Pes). Cardiac output (CO) was 
calculated from HR multiplied by SV.  
From the occlusion analysis, we calculated the slope (Ees) and volume axis intercept 
(V0) of the end-systolic pressure-volume relationship (ESPVR, Figure 1D). We derived also 
the slope of the end-diastolic pressure-volume relationship (EDPVR), the preload-recruitable 
stroke work (PRSW), with stroke work assessed from the area enclosed by the pressure-
volume loop, as well as the preload adjusted dP/dtmax expressed as the slope of the relation 
between dP/dtmax and end diastolic volume. Data acquisition was provided at a sampling rate 
of 1kHz and analyzed using IOX (EMKA, Paris, France). 
 
      
Assessment of cardiac structure. For the histology, heart tissue samples were fixed in 
4% formaldehyde, mounted in paraffin block and slices were obtained with a microtom. After 
deparaffinization and hydratation the samples were treated with either periodic acid Schiff 
(PAS) staining (Sigma) protocol (to discriminate cell borders) or 0.1% picrosirius red (for 
collagen, Sigma). The mean of the cardiomyocyte cross-sectional area and diameter were 
calculated by photomicrographs of 100 cells/specimen with a computer assisted image 
analysis system (Metamorph analysis). 
Assessment of cardiac structure using echocardiographic measurements. TTE was 
performed as previously described [17]. In brief, at baseline and every two weeks for an eight 
week period with a commercially available echocardiographic system (C256 Sequoia, 
Acuson, Mountain View, CA, USA) with the animal in the left lateral decubitus position. 
Light anesthesia was used during the analysis with Isofluorane ventilated inside a nose-cone 
at 0.5l/min with 100% oxygen (Forene, Abbott AG, Baar, Switzerland). Once asleep, the rat 
was shaven with an electrical razor (Surgical clipper 9661, 3M health care, MN, USA). 
Ultrasound transonic blue gel (Tyco healthcare/Kendall, Mallinckrodt Dar, MO, Italy) was 
placed on the thorax to optimize visibility of the cardiac chambers. A 15MHz linear array 
transducer (15L8) was used with a frame rate of 100Hz using bidimensional and color 
Doppler imaging. The probe was placed to obtain short and long axis and four chamber 
views. From the long axis view, an M-mode trace of the LV was obtained, and LV end-
diastolic diameter (LVDed), LV systolic diameter (LVDes), and posterior and septal wall 
diastolic wall thickness (PWth and SWth) were measured. LV mass was calculated as = 
(((LVDed+SWth+PWth)3 –LVDed3)*1.04)*0.8+0.14 (in grams, with LV dimensions 
expressed in mm). Relative wall thickness was assessed as RWT = (PWth+SWth)/(LVDed).  
Wave reflection analysis. Aortic pressure, Pao, was separated into its forward (Pf) and 
backward (Pb) running components using the linear wave separation method [45]: 
 
      
Pf = (Pao + Zc * Qao) /2  and Pb = (Pao − Zc *Qao) /2 
An example of the aortic pressure wave and its forward and backward (reflected) components 
is shown in Figure 1E. The backward component is the sum of all reflected waves travelling 
towards the heart [45]. To characterize wave reflections, the reflection coefficient () was 
computed as [45]: 
Γ = (Zin − Zc) /(Zin + Zc) 
Γ is a frequency-dependent complex quantity. In order to facilitate comparison between the 
groups we computed and compared the modulus of the reflection coefficient at the 1st 
harmonic, |Γ1|, which is assumed to be representative of the general wave reflection properties 
of the arterial tree. The time of the arrival of the foot of the reflected wave was defined as ∆t 
(Figure 1E). The shorter the ∆t, the stronger the systolic pressure augmentation resulting from 
wave reflections.  
Coupling parameters. Arterial elastance (Ea) was calculated as the ratio of Pes divided 
by SV and the coupling parameter Ea/Ees computed [42]. Efficiency, defined as the ratio of 
stroke work over pressure-volume area (PVA; stroke work plus potential energy) was 
calculated. In addition to the “conventional” coupling parameter, we also calculated two 
recently proposed ventricular-arterial coupling parameters [41]. The first one is the 
“Compliance Coupling Index, CCI” expressed as the product of characteristic chamber 
elastance (EesxC), Ees being the inverse of ventricular compliance at end systole and C arterial 
compliance. Second, the “Temporal Coupling Index, TCI”, expressed as the ratio of 
characteristic times (RC/T), T being the heart period and RC the characteristic diastolic 
pressure decay time which is a combination of the capacitive-resistive properties of the 
arterial tree [40].  
Tissue calcium content. A 10mm sample of the descending thoracic aorta as well as 
the cardiac apex were removed, and tissue calcium content (µmol/g dry wt) was determined 
 
      
by atomic absorption spectrophotometry (AA10;Varian) after mineralization and acid 
digestion of the tissue [13]. 
Statistical analysis. Values are given as mean ± SD. Differences were determined by 
the unpaired Student’s t-test, and the null hypothesis was rejected at p<0.05. A linear 
regression analysis was also performed between calcium and all other parameters. All 
analysis was done using SPSS (SPSS 11.5, SPSS Inc, Chicago, IL, USA).  
 
 
Results 
 
Basic hemodynamic parameters. At eight weeks post VDN treatment (sacrifice), the 
heart weight (HW) and HW/BW ratio were both significantly greater in the VDN group 
(p<0.05, Table 1). Systolic and pulse pressures were both higher in the VDN group (p<0.01, 
Table 1). Pes rose significantly in the VDN group (p<0.05, Table 1), however, LVEDP 
remained unaltered. Pes values were higher than SBP due to the fact that Pes was measured at 
the beginning of the experiment whereas SBP at the end of the occlusion analysis, when 
pressures were overall lower.  
 
 
 
 
 
 
 
 
 
 
 
 
 
      
Table 1. Values are mean ± SD. Comparison between the two groups for different invasive indices analyzed at 
sacrifice with the conductance catheter. HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; MAP, mean arterial pressure; PP, pulse pressure; Pes, LV end-systolic pressure; LVEDP, left 
ventricular end-diastolic pressure; V0, slope and intercept of the end-systolic pressure-volume (PV) relation; 
HW/BW, heart weight ratio over body weight. *p<0.05, †p<0.01 CTRL vs VDN at same age. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters Control Group VDN Group 
HR (bpm) 360±25 390±27* 
Body weight (g) 463±47 421±62 
Heart weight (g) 1.04±0.16 1.23±0.08† 
Heart/body weight 2.16±0.32 2.46±25* 
SBP (mmHg) 110±9 136±7† 
DBP (mmHg) 80±6 91±8 
MAP (mmHg) 90±7 102±7 
PP (mmHg) 29±5 47±9* 
Pes (mmHg) 128±15 148±15* 
H
em
od
yn
am
ic
s 
LVEDP (mmHg) 8.6±2.4 7.4±3.9 
Arterial alterations. Aortic internal diameter was higher in the VDN group (p<0.05) 
but medial thickness remained unchanged (Figure 2).  
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Figure 2. Panel A: Cardiomyocyte hypertrophy was estimated from LV section from control and VDN treated 
groups. Upper panels show representative cardiomyocyte cross-sectional and diameter as revealed by histology 
using periodic acid schiff. Below, show cardiomyocyte length as visualized by immuhistochemistry using double 
staining with antibodies against laminin (red) and connexin 43 (green). Panel B: The two groups representing 
cardiomyocyte diameter and Panel C: cross sectional area (CSA). Panel D: Aortic sections of the thoracic aorta 
in representative rats from the CTRL and VDN groups. The first cm of the descending thoracic aorta was 
removed, fixed in formaldehyde (10% in phosphate buffered saline) and embedded in paraffin for 
histomorphometric analyses. For each rat, three sections (thickness 20 µm) were cut and stained with 
hematoxylin-eosin for the measurement in a double-blind fashion of mean internal diameter and medial 
thickness (h, mean of 4 measurements of the distance (double white arrow) between the external and the internal 
elastic laminae (black arrows)). Panel E: The two groups representing aorta internal diameter (Di) and Panel 
F: medial thickness (h). 
      
However, their ratio (h/Di) remained unchanged (Table 2). Arterial WS was similar in control 
and in VDN rats, but the EM was significantly higher in VDN (p<0.05, Table 2). The ratio, 
EM/WS was significantly elevated in the VDN rats (p<0.05, Table 2). There was a substantial 
(-43%, p<0.05) decrease in C and increase in PWV (p<0.05, Table 2) in the VDN group. 
Systemic vascular resistance, R, was similar between the groups (Table 2). There was a trend 
towards elevated aortic characteristic impedance, Zc (Table 2).  
 
Table 2. Values are mean ± SD. Comparison between the two groups for arterial indices analyzed at sacrifice 
with the conductance catheter. R, total systemic vascular resistance; C, total arterial compliance; Zc frequency 
domain estimate of Zc; PWV, pulse-wave velocity; Di, internal diameter; h, wall thickness; EM, elastic modulus 
and WS, wall stress. *p<0.05, †p<0.01 CTRL vs VDN at same age. 
 
 
 
 
Parameters Control Group VDN Group 
 Di (mm) 1.46±0.05 1.66±0.04* 
 h (µm) 78±11 87±10 
h/Di 0.053±0.004 0.053±0.008 
R (mmHg/(ml/s)) 1.67±0.48 1.87±0.88 
C (ml/mmHg) 0.21±0.04 0.12±0.08* 
Zc ( mmHg/(ml/s)) 0.06±0.01 0.08±0.02 
PWV  (m/s) 5.1±2.0 8.8±2.5* 
EM (106 dyne/cm2 ) 6±5 19±8* 
WS (106 dyne/cm2 ) 1.2±0.2 1.4±0.3 
A
rte
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Calcium (µmol/g dry wt) 17±1 442±174* 
 
 
      
Figure 3 displays the averaged Zin spectra in terms of modulus and phase angle. The mean 
values of the modulus of the input impedance of the VDN group were consistently higher 
than that of the control for all frequencies, indicating the loss of compliance in the VDN 
group (Figure 3). The phase angle crossed the frequency axis at about 30Hz for the CTRL and 
43Hz for the VDN. This shift of the zero phase cross over towards higher frequencies is also 
indicative of higher wave velocity in the VDN group (Figure 3). Calcium in the aorta 
increased by a factor of 28 in the VDN group compared to controls (Table 2).  
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Figure 3. Modulus (A), modulus magnified at 0.1mmHg/(ml/min) in order to emphasize the difference between 
the two groups (B) and phase (C) of the input impedance (Zin) spectra. Solid line gives the calculated average 
and the error bars are SD. ♦ represents the CTRL group and ■ the VDN one.  
Cardiac alterations. SV was significantly lower in the VDN group, but cardiac output 
was maintained due to the significantly higher HR in this group (Table 1 and 3). There was 
slight LV chamber shrinkage in the VDN group, reflected by significantly smaller EDV and 
ESV’s (Table 3). The volume intercept of the ESPVR, V0, increased significantly in the VDN 
group (p<0.05, Table 3). Contractility was significantly augmented in VDN rats, and this is 
reflected by a substantial increase in all related indices: Ees increased by 71%, PRSW by 34%, 
and the slope of the dP/dtmax-EDV relation increased by 100% (p<0.05, Table 3). EDPVR 
remained the same. As a consequence of identical EDPVR and augmented Ees, there was a 
tendency for higher EF in the VDN group (Table 3).  
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
Table 3. Values are mean ± SD. Comparison between the two groups for cardiac structure, function and 
composition analyzed at sacrifice with the conductance catheter. dP/dtmax (preload dependent) and the preload 
adjusted dP/dtmax (dP/dtmax vs EDV); EF, ejection fraction; PRSW, preload recruitable stroke work; Ees, end-
systolic elastance; EDPVR, end-diastolic pressure-volume relationship; CO, cardiac output; SV, stroke volume; 
EDV, end-diastolic volume; ESV, end-systolic volume; PVA, pressure-volume area; *p<0.05, †p<0.01 CTRL vs 
VDN at same age. 
 
Parameters Control Group VDN Group 
SV (ml) 0.15±0.03 0.11±0.03* 
EDV (ml) 0.27±0.05 0.18±0.04* 
ESV (ml) 0.11±0.04 0.07±0.04* 
dP/dtmax (mmHg/ms) 7100±1300 7900±700 
dP/dtmin (mmHg/ms) -7600±1300 -8500±900 
dP/dtmax  -  EDV (mmHg/s/µL) 21±7 42±26* 
PRSW (mmHg) 77±22 103±18* 
EF (%) 59±8 64±12 
Ees (mmHg/µL) 1.27±0.60 2.07±0.90* 
Vo (µL) -114±66 -41±77* 
EDPVR (mmHg/µL) 0.03±0.01 0.03±0.02 
PVA (Joules) 36±18 20±10* 
CO (ml/min) 55±11 56±26 
C
ar
di
ac
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Calcium (µmol/g dry wt) 6.3±0.9 9.8±1.1* 
 
 
 
      
 
 
RWT increased significantly in the VDN group, as did the LV mass measured with TTE 
(Figure 4). Calcium in the myocardium increased by a factor of 1.6 in the VDN group (Table 
3). Cardiomyocyte diameter and CSA were both significantly augmented in the VDN group 
(Figure 2). The significance is related to the high numbers of counted myocytes during the 
analysis procedure.  
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Figure 4. TTE M-mode of the CTRL and VDN rats showing hypertrophy of the posterior and septal walls of the 
long axis LV view in the VDN rat.  
 
 
 
 
 
 
 
 
      
 
 
 
Wave analysis. A typical set of aortic pressure and flow waves for control and VDN 
rats is given in Figure 5.  
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Figure 5. Pressure (A, CTRL and B, VDN) and flow (C, CTRL and D, VDN) measured in the aorta of control 
(left) and VDN-treated rats (right). Pressure is separated into its forward running wave component (Pf) and the 
reflected wave component (Pb). 
 
It also shows the forward running and reflected waves, as obtained by the linear wave 
separation method. A significant difference in the shape of the pressure waves is observed. 
For the control group, the aortic pressure wave is of Type C, typical of the form of aortic 
pressure in young adults, characterized by the absence of reflected waves during systole 
[Murgo et al.]. This absence of significant wave reflection during systole is reconfirmed by 
 
      
the existence of a very shallow reflected wave (Figure 5 A). For the VDN group, the aortic 
wave is of Type A, typical of that of an aged individual with a stiff arterial tree, characterized 
by a late systolic augmentation in the pressure wave. This augmentation is related to the 
arrival of a relatively strong wave reflection in mid-systole, as seen in Figure 5B. The 
amplitude of the reflected wave, |Pb|, increased by almost 40% in the VDN group (p<0.05, 
Table 4) and this is concurrent with an increase in the modulus of reflection coefficient 
(p<0.05, Table 4). The time of arrival of the reflected wave, ∆t, was somewhat shorter in the 
VDN group (p=ns). 
Ventricular-arterial coupling. Ea rose insignificantly in the VDN group (Table 4). Ea 
/Ees dropped in the VDN group reflecting alterations caused by the VDN diet (Table 4). The 
compliance coupling index, CCI=Ees x C, remained practically unaltered (Table 4). On the 
contrary, the temporal coupling index, TCI= RC/T, was significantly reduced in the VDN 
group (-26%, p<0.05, Table 4). Efficiency augmented significantly in the VDN group due to 
the reduction of the PVA (p<0.05, Table 3 and 4).  
Table 4. Values are mean ± SD. Comparison between the two groups for coupling and wave analysis indices 
analyzed at sacrifice with the conductance catheter. Ea, effective arterial elastance; Ea/Ees, effective arterial 
elastance over end-systolic elastance; Ees x C, end-systolic elastance product compliance; RC/T, resistance-
 
Parameters Control Group VDN Group 
Ea  (mmHg/µL) 0.89±0.24 1.41±0.46* 
Ea/Ees   0.70±0.53 0.60±0.17 
Ees x C  0.34±0.14 0.32±0.08 
RC/T  2.3±0.6 1.7±0.4* 
C
ou
pl
in
g 
pa
ra
m
et
er
s 
Efficiency (%) 0.35±0.11 0.48±0.10* 
Pb (mmHg) 8.4±1.0 13.3±3.1* 
∆t (ms) 0.015±0.002 0.013±0.003 
W
av
e 
re
fle
ct
io
n 
an
al
ys
is
 
Γ  0.52±0.05 0.63±0.06* 
 
      
compliance product over time period; Pb, backward wave amplitude; tr, time point at which the backward wave 
arrives and Γ reflection coefficient. *p<0.05, CTRL vs VDN at same age. 
 
 
Discussion  
We evaluated the long-term effects of VDN on arterial function, cardiac function and 
ventricular- arterial coupling in rats. Treatment with VDN lead to a stiffened arterial tree 
similar to aged-related arterial calcification, which is elucidated by reduced arterial 
compliance Arterial stiffening, had a significant effect on wave reflections and ventricular-
arterial coupling. VDN also caused LV concentric hypertrophy and lead to augmented cardiac 
performance. 
Arterial stiffness, hypertension and cardiovascular risk. Arterial stiffening, either as a 
result of aging or of pathological changes in the arterial wall, leads to increases in systolic and 
PP [27]. Systolic blood pressure and pulse pressure (PP), in particular, have been 
demonstrated to be strong independent predictors of cardiovascular mortality [10,33]. The 
mechanisms linking arterial stiffness to ISH have been clearly identified and discussed in 
detail [45]. It is thus suggested that one should not only monitor PP and SBP to assess 
cardiovascular risk, but also the hemodynamic factors influencing SBP and PP, namely 
ventricular ejection, aortic stiffness and wave reflections [9,33,35,37]. In a recent review, 
aortic stiffness (PWV) and an early return of reflected waves to the heart have been 
established as independent predictors of cardiovascular risk [35].  
Models of stiff arterial trees. Various animal models of chronic arterial stiffness have been 
reported in the literature, such as young SHR rats [12], Dahl salt-sensitive rats [16], DOCA-
salt hypertension rats [34], VDN rats [2] and others. In some of the above models, however, 
arterial stiffening is not the primary effect.  
Effect of VDN on baseline hemodynamics and arterial function. In our study, treatment with 
 
      
VDN leads to increases in systolic and PP (Table 1). This is in agreement with earlier studies 
in VDN-treated rats, where systolic pressure and pulse pressure was found to increase 
whereas mean pressure remained constant and diastolic pressure decreased [20].  
In previous studies, increase in aortic stiffness was represented by increases in aortic 
characteristic impedance, PWV and elasticity modulus, and occurred in the absence of any 
changes in mean blood pressure, geometry, or wall stress [20,29]. Our study shows similar 
findings, except that we found a slight rise in Di in the VDN group which has, however also 
been reported in a setting with 90 days VDN treatment [43]. However, this rise in Di had no 
effect on wall stress and its influence on the elasticity modulus is minimal. Further the 
thickness to diameter ratio, h/Di, is the same in the two groups, which leads to similar mean 
stresses in the arterial wall in control and VDN.  
Lartaud-Idjouadienne et al. found, however, that VDN affected only the elastic and 
not the resistive properties of the arterial system, with aortic characteristic impedance being 
increased by 56% whereas total peripheral resistance remained unchanged [20]. We know 
from earlier studies in the human [24] and other mammals [30,31,36] that when cardiac 
output and peripheral resistance are maintained while compliance is decreased, this results in 
an increased systolic pressure and a decrease in diastolic pressure, which is consistent with 
the findings of Lartaud-Idjouadiene et al [20,21]. This is in agreement with our findings 
(Figure 3) showing that the modulus of the input impedance of VDN rats for the first 5 
harmonics was typically 35% higher than controls, and this corresponds well with the increase 
in pulse pressure (+36%). Characteristic impedance, Zc, estimated as the average impedance 
modulus, rose but not significantly, the significance been hindered by the large standard 
deviations in the impedance moduli of the VDN group (Table 2). The change in mean value 
of the characteristic impedance is, however, consistent with the decrease in compliance in the 
VDN rats (Table 2). Zc is proportional to the inverse square root of aortic compliance and 
 
      
aortic compliance is the main determinant of total systemic compliance. Indeed, the ratio of 
Zc,CTRL/Zc,VDN=0.060/0.082=0.73 is very close to the ratio CVDN /CCTRL = 0.12 /0.21 = 0.75, 
demonstrating that changes in compliance and aortic characteristic impedance are consistent. 
In our study, aortic calcium compared well to previous reports on the effect of VDN 
on aortic wall composition and that elastocalcinosis is the major determinant of the induction 
of aortic stiffness in the VDN model [20, 21, 25, 29, 43]. Also, when a subgroup analysis was 
performed separating low from high calcium levels in the aorta; the level of calcium was 
found to be directly proportional to the level of augmented SBP being 148±13mmHg (low) 
and 171±14mmHg (high). More so, a direct correlation could be established between aortic 
calcium and SBP (r=0.91, p=0.005). Furthermore, in the present study, as in previous ones, 
calcinosis was stronger in the aortic wall than in the myocardium in VDN rats, as calcium 
deposits occur preferentially inside tissues containing elastic fibers, with a gradient of calcium 
content as follows: thoracic aorta > abdominal aorta ≥ carotid artery > kidney > caudal artery 
> myocardium > mesenteric bed [13]. 
Effect of VDN on cardiac structure and function. Lartaud et al. and others studied the 
consequences of VDN-induced arterial stiffening on certain cardiac structure, composition 
and performance parameters [4,20,32]. Lartaud et al. found that following VDN treatment, 
heart rate, stroke volume, cardiac output and stroke work were maintained whereas LV 
weight/body weight increased, suggesting hypertrophy. In our study, contrary to the above, 
we found that SV was compromised and CO maintained probably due to the fact that HR 
(+8%) was elevated after VDN treatment. More so, heart weight and its ratio with body 
weight rose after VDN treatment as did our non-biochemical indicators of hypertrophy. This 
is also the first time cardiac volumes have been measured post VDN treatment using 
conductance catheter techniques and validation with TTE.  
 
      
Lartaud-Idjouadiene et al., gave considerable information on LV tissue composition 
but they did not quantify diastolic and systolic cardiac function in detail [20]. We have found 
that diastolic filling pressure as well as EDPVR remained unchanged, meaning that the 
diastolic function of the heart is preserved in the VDN group (Tables 1 and 2). Cardiac 
contractility, however, is significantly enhanced in the VDN group, as this is reflected by a 
100% increase in both Ees, and the slope of dP/dtmax- EDV relationship (Table 2). This is as 
expected from the previously published data from Lartaud et al. due to the LV hypertrophy 
and rise in β-MHC isoform [20]. The β-MHC isoform develops a slower, more efficient form 
of contraction. Another reason could be changes in LV stiffness due to the moderate but 
significant increase in myocardial collagen content, thus interstitial fibrosis could be involved 
in the mechanism as reported in earlier studies [20].  
Effect of VDN on wave reflections. Arterial stiffening, such as in ageing and 
hypertension, increases the amplitude of the arterial pulse wave and PWV, causing early 
return of reflected waves to the aorta. This, in turn, results in an associated increase in systolic 
and PP [35,44]. There is a strong correlation between the early return of wave reflections in 
the aorta and left ventricular hypertrophy [22]. Our results are in agreement with the above 
and this is the first time comprehensive wave analysis was analyzed in the VDN model. 
Indeed, the decrease in compliance caused by VDN is associated with an increase in PWV 
(Table 2), an increase in the amplitude of the reflected wave and a decrease in time of arrival 
of the reflected wave (Table 4), which indicates stronger wave reflections arriving earlier in 
systole. The larger amplitude of the reflected wave is further corroborated by the increased 
reflection coefficient. More so, a direct correlation could be established between aortic 
calcium and the amplitude of the reflected wave Pb (r=0.84, p=0.02)  
Effect of VDN on ventricular-arterial coupling. Ventricular-arterial coupling is often 
judged upon optimal cardiac energetics, i.e., the ability of the heart to deliver optimal power 
 
      
or operate under maximal efficiency [46] characterized by the ratio of Ea/Ees. It has been 
suggested that the heart delivers maximum SW when Ea/Ees =1, whereas optimal efficiency is 
obtained when Ea/Ees =0.5 [6]. As the ratio augments above 1.3 and below 0.3, the SW and 
efficiency are both compromised [16] as observed in patients with severe cardiac dysfunction 
[1]. Changes in ventricular-arterial coupling due to arterial stiffening with VDN have not been 
reported so far. We found that after treatment with VDN both Ea and Ees increased 
significantly as seen in aging [18] (Table 2 and 3), thus the ratio Ea/Ees was relatively 
preserved (Table 3). Due to the fact that Ea/Ees approaches 0.5 in the VDN group, optimal 
efficiency is attained therefore rises significantly due to a reduction of PVA (Table 3). 
Optimal energetic coupling of the heart and the arterial system has been reported to be 
preserved in hypertension and aging [8,18,38]. Although widely used, Ea/Ees has been 
criticized for not being a true coupling index [38]. This is because Ea is approximately equal 
to R/T, therefore the effective arterial elastance is primarily a measure of peripheral resistance 
and does not reflect the elastic properties of large conduit arteries. Further, Ea includes the 
effects of heart period, which is a cardiac parameter; therefore Ea is not a pure arterial 
parameter. In that respect, we have computed two other non-dimensional coupling 
parameters: the CCI and the TCI [41]. We found that the CCI (EesxC) was maintained in the 
VDN group (0.32±0.08 in VDN vs. 0.34±0.14 in CTRL, Table 4). This means that the 
stiffening of the arterial tree after VDN was followed by a proportional increase in systolic 
LV chamber stiffness. Although CCI has been identified as an important coupling parameter 
and independent determinant of SV and aortic pressure [41], there are no reports on how this 
index behaves in arterial or cardiac disease. To the best of our knowledge, this is the first 
report showing that CCI is maintained during development of isolated systolic hypertension 
after arterial stiffening. Contrary to CCI, the TCI (RC/T) was compromized after VDN 
 
      
treatment. This is because the decrease in compliance in the VDN group was not fully 
compensated by the increase in peripheral resistance and the slight increase in heart rate.  
Clinical implications, novelty and validity. The present work offers a comprehensive 
study of ventricular-arterial coupling in presence of VDN-induced systolic hypertension. The 
effects of VDN treatment were analyzed at both the arterial level and the cardiac level, as well 
as in the framework of ventricular-arterial interaction. Most of previous work focused on the 
effects of VDN treatment on heart and vessels, but there was neither a report on cardiac 
mechanics and energetics, nor on the effect on ventricular-arterial coupling [2,20]. The 
comprehensive character of the study, which offers a consistent set of arterial, cardiac and 
ventricular-arterial data on the same animal model may be valuable for the global 
understanding of the pathophysiological phenomena involved in the development of systolic 
hypertension in presence of a stiffened arterial system. Further research at a molecular level is 
encouraged in order to elucidate the effects of VDN on cardiac function [4]. 
In conclusion, we have studied hemodynamics, arterial function, cardiac function and 
ventricular-arterial coupling in a rat model of reduced arterial compliance. The results show 
that arterial stiffening after VDN treatment provokes important changes in vascular 
impedance and wave reflections due to isolated systolic hypertension and LV hypertrophy 
while ventricular-arterial coupling was also altered. The effects are quantitatively similar to 
those of arterial stiffening with age. 
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Abstract 
 
Background: Epidemiological studies have shown that coronary heart disease and 
hypertension independently influence the development of heart failure (HF). We therefore 
hypothesized that a model combining myocardial infarction (MI) and isolated systolic 
hypertension (ISH) by way of vitamin D3 and nicotine (VDN) mediated aortic elastocalcinosis 
would be of particular interest in order to translate basic research findings into clinical 
 
      
applications.  
Methods and Results: Wistar rats were treated with VDN (VDN, n=9), subjected to 
myocardial infarction by coronary ligation (MI, n=10) or to a combination of both MI and 
VDN treatment (VDN/MI, n=14). A sham treated group served as control (CTRL, n=10). 
Trans-thoracic echocardiography was performed every 2 weeks whereas invasive indices 
(conductance catheter) were obtained at week 8 before sacrifice. Calcium, collagen and 
protein contents were measured in the heart and the aorta. The heart weight and lung weight 
to body weight ratios were highest in the VDN/MI group. Also the ejection phase indices 
(ejection fraction, cardiac output, stroke volume, fractional shortening) were most 
compromised in this group. Cellular hypertrophy was increased in the VDN/MI group as 
compared to other groups. Cardiac calcium and collagen were highest in both MI groups. 
Brain natriuretic peptide was greatest in the VDN/MI group.  
Conclusions: The combination of ISH and MI demonstrates larger compromises in cardiac 
structure and function of heart failure as compared to other models of HF. This model mimics 
several clinical phenomenon and may thus serve to further study novel therapies. 
 
Keywords: calcium, echocardiography, heart failure, hypertension, myocardial infarction. 
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Introduction  
 
Epidemiological studies have shown that coronary heart disease (CHD) and arterial 
hypertension are independent predictors of congestive heart failure (HF), the occurrence being 
40% when both pathologies are associated [1. However, most experimental models are based 
on a single cause. Therefore, the development of a model combining myocardial infarction 
(MI) and hypertension would be of particular interest. 
Whereas MI models are relatively well developed, there are several possibilities to induce 
 
      
arterial hypertension in small animals. Spontaneously hypertensive rats (SHR) [2], renal 
hypertensive models [3,4], and Dahl salt-sensitive and salt-resistant rats [5] are typical models 
of essential hypertension. In patients however, the aged-related alterations in aortic structure 
are common and include the degeneration and fragmentation of elastic fibers, progressively 
leading to a loss of compliance [6]. Today, the subsequent chronic early return of a reflected 
pressure wave to the heart is accepted as an independent cardiac risk factor [7,8]. This 
phenomenon could be reproduced and studied in dogs after replacement of the thoracic aorta 
by a plastic tube [9]. In small animals, calcinosis and stiffening of the aorta can be induced by 
administration of vitamin D3 and nicotine (VDN) [10,11] and leads progressively to the 
development of isolated systolic hypertension (ISH) and compensatory left ventricular (LV) 
hypertrophy [12-15].  
The combination of ISH together with MI has not yet been evaluated in small animal models. 
We therefore hypothesized that such a model would show aggravated signs of cardiac 
dysfunction and accelerated evolution toward HF as compared to either of the two 
pathologies, and would represent therefore a novel small animal model of HF better 
mimicking the patho-physiological alterations found in the clinical environment. 
 
Material and methods 
Animals. Male Wistar rats, 2 months old (Charles River, Lyon, France) were 
maintained in temperature and humidity controlled rooms with a typical light-dark cycle and 
given standard chow and mineral water (Mont Roucous, France) ad libitum. The investigation 
conforms to the Guide for the Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH Publication No. 85-23, revised 1996).  The protocol was 
approved by our local ethical committee. 
Animals (n=64) were randomized into four age- and weight-matched groups as 
follows:  
 
      
Control group (CTRL, n=10, 226±7g). At day 1, the animals received normal saline 
intramuscularly (volume equivalent to the VDN group below) and underwent two 5ml/kg 
gavages of distilled water at 9AM and 5PM. At week 3, animals were anesthetized with 
Isofluorane (Forene, Abbott AG, Baar, Switzerland), intubated, ventilated (100% oxygen, 60 
cycles/minute, tidal volume of 2ml, Harvard Apparatus Inc model 683, Holliston, Ma, USA) 
and placed on a heating pad before a sham operation was performed (left thoracotomy in the 
3rd intercostal space and opening of the pericardium). The thorax was closed .Analgesia was 
then administered IP (40mg/kg) and again 24 hours post surgery (Pro-Dafalgan, Upsamedica 
SA, Baar, Switzerland). 
VDN group (VDN, n=15, 226±8g). The procedure was previously described in detail 
[Lartaud 1999]. Briefly, on day 1 at 9AM, 300’000 IU/kg of vitamin D3 (Duphafral D3 1000, 
Duphar BV, Weesp, The Netherlands) was injected in the hind leg muscle and 25mg/kg 
nicotine (Nicotine hydrogen tartrate, Sigma Chemical Company, MO, USA) in 5ml/kg sterile 
water was given orally by gavaging. Gavaging was repeated once at 5PM the same day. Three 
weeks later, the animals underwent a sham operation (see CTRL group for description).  
Myocardial infarction group (MI, n=10, 243±7g). At day 1, the animals were treated 
similarly as animals of the CTRL group At week 3,.an MI was induced by ligation of the left 
anterior descending coronary. 
Combined VDN and MI  group (VDN / MI, n=29, 213±24g). The animals received the 
VDN treatment at day 1 and underwent a MI at week 3 according to the procedures detailed 
above.  
Annexe concerning the therapy schedule for the four groups over the study period.  
Group Day 1 Week 2 Week 3 Week 4 Week 6 Week 8 
 
      
CTRL 
 Placebo TTE Sham TTE TTE TTE + CC 
MI 
 Placebo TTE MI TTE TTE TTE + CC 
VDN 
 VDN TTE Sham TTE TTE TTE + CC 
VDN / MI 
 VDN TTE MI TTE TTE TTE + CC 
 
Invasive cardiac measurements (Conductance Catheter). At week 8, the animals were 
reanaesthetized, intubated and the right jugular vein and carotid artery were isolated. A 2Fr 
conductance catheter (SPR 838 Aria®, Millar Instruments Inc, Texas, USA) was inserted into 
the ascending aorta via the right carotid artery. The systolic (SBP), diastolic (DBP), mean 
(MBP) and pulse pressures (PP) were obtained. Thereafter, the CC was advanced into the LV. 
Parallel conductance was measured after injection of 20µL of 10% saline into the jugular vein 
in accordance to the method by Baan et al. [16]. An occlusion analysis was performed by 
temporarily occluding the inferior vena cava below the diaphragm via a mini laparotomy. For 
each animal, the CC calibration correction factor alpha was assessed with the use of an 
ultrasonic flowmeter (Transonic, Ithaca NY, USA) placed around the ascending aorta.  
Regarding further parameter descriptions, the subscript ‘c’ refers to data measured 
with the conductance catheter in order to differentiate from the same parameters measured 
with TTE (denoted by the subscript “e”). The following parameters were derived: Stroke 
Volume (SV), end-systolic volume (ESV), end-diastolic volume (EDV), ejection fraction (EFc 
= SV/EDV), isovolumetric contraction time (ICT), peak positive (dP/dtmax) and peak negative 
(dP/dtmin) value of the time-derivative of LV pressure, contractility index (dP/dtmax divided by 
the pressure at this point), isovolumetric relaxation time (IRT, duration of the isovolumic 
 
      
relaxation), time constant of relaxation derived from the peak systolic pressure to the next 
begin of diastolic pressure (Tau), heart rate (HR) and left ventricular end-diastolic (LVEDP). 
Cardiac output (COc) was calculated as SV multiplied by HR. 
From the occlusion data, we calculated the slope (Ees) and volume axis intercept (V0) of the 
end-systolic pressure-volume relationship (ESPVR), the slope of the end-diastolic pressure-
volume relationship (EDPVR), preload-recruitable stroke work (PRSW) (with stroke work 
assessed from the area enclosed by the pressure-volume loop), preload adjusted dP/dtmax 
(slope of the relation between dP/dtmax and end diastolic volume (EDV)), potential energy 
(PE) and pressure-volume area (PVA). The ratio of stroke work and PVA is a measure of 
efficiency.  
Echocardiographic measurements. Trans-thoracic echocardiography (TTE) (C256 
Sequoia echocardiographic system, Acuson, Mountain View, CA, USA) was performed at 
baseline in 15 arbitrary rats before they were randomized into the 4 groups. Thereafter, a new 
TTE was performed in each rat every second week until week 8. Animals were lightly 
anesthetized with Isoflurane (Forene, Abbott AG, Baar, Switzerland) ventilated inside a nose-
cone (0.5l/min, 100% oxygen) and positioned on their left side. A 15MHz linear array 
transducer (15L8, Acuson, Mountain View, CA, USA) was used using bidimensional and 
color Doppler imaging. The probe was placed to obtain short and long axis and four chamber 
views. From the long axis view, an M-mode trace of the LV was obtained, and LV end-
diastolic diameter (LVDed), LV systolic diameter (LVDes), and posterior and septal wall 
diastolic wall thickness (PWth and SWth) were measured. LV fractional shortening (LVFS) 
was calculated according to = (LVDed-LVDes)/LVDed x100. Ejection fraction was 
calculated from a long axis view using planimetry (EFe) = 100 x (LVDed3 –LVDes3)/LVDed3. 
Velocity of circumferential fiber shortening (Vcf) was calculated using the following formula 
(LVDed-LVDes)/(ET x LVDed). EDV and ESV were calculated using the Simpson’s 
 
      
method, and SV was calculated as EDV-ESV. Aortic flow or cardiac output (COe) was 
recorded and calculated using pulse Doppler imaging, with the smallest possible sample 
volume placed at the level of the aortic annulus. Doppler yields the velocity profile (aortic 
velocity time integral (VTI)) which is multiplied with the cross sectional area of the outflow 
tract to obtain flow. Integration of the velocity profile yields the aortic velocity time integral. 
LV mass was calculated as = (((LVDed+SWth+PWth)3 –LVDed3)*1.04)*0.8+0.14 (in grams, 
with LV dimensions expressed in mm). Relative wall thickness was assessed as RWT = 
(PWth+SWth)/(LVDed). LV ejection time (ET) was measured as the time from the beginning 
to the end of the aortic flow wave. IRT was measured as the interval between the aortic 
closure click and the start of mitral flow, while ICT was obtained as the time delay between 
the cessation of mitral inflow and the onset of aortic ejection. Additionally, the mitral valve 
closure time (MCO) was measured. The myocardial performance index (MPI) is then defined 
as (MCO-ET)/ET = (ICT+IRT)/ET. 
Cardiac and vascular tissue calcium content. A 10mm sample of the descending 
thoracic aorta as well as the cardiac apex were removed, and tissue calcium content (µmol/g 
dry wt) was determined by atomic absorption spectrophotometry (AA10;Varian) after 
mineralization and acid digestion of the tissue [17]. 
Scleroprotein analysis. Collagen content was measured from hydroxyproline content 
using protein hydrolysis followed by colorimetric spectrophotometry.  
Vascular histomorphometry. Aortic geometry, internal diameter and medial thickness 
were then determined by computer-directed color analysis (Quant’Image software, Talence, 
France).  
Vascular function. Pulse wave velocity (PWV) was estimated indirectly from the 
characteristic impedance and ascending aorta dimensions as PWV= Zc*A/, where A=r2 is 
the luminal cross-sectional area of the ascending aorta measured with echocardiography and 
 
      
  being the density of blood. After euthanasia, the aorta was excised and a 5mm sample of 
the descending aorta was dehydrated in graded ethanol solutions and embedded in paraffin. 
Three 20µm thick sections were stained with hematoxylin-eosin for measurements of internal 
diameter (Di) and medial thickness (h) (Saisam, Microvision Instruments)[12]. Elastic 
modulus (EM; 106 dyne/cm2) was calculated according to the Moens-Korteweg equation: EM 
=(PWV2 x Di x ρ)/h, where PWV (cm/s) is pulse wave velocity and ρ =1.05g/ml (blood 
density). Wall stress (WS; 106 dyne/cm2) was calculated from the Lamé equation: WS= (MAP 
x 1333 x Di)/2h. The ratio h/Di was also calculated.  
Cardiac infarct size and histology. After completion of these measurements, LV was 
excised and weighed. The infarct size area (IS) was determined as a percentage of the entire 
LV area, as reported previously [18]. For the histology, heart tissue samples were fixed in 4% 
formaldehyde, mounted in paraffin block and slices were obtained with a microtom. After 
deparaffinization and hydratation the samples were treated with either periodic acid Schiff 
(PAS) staining (Sigma-Aldrich Chimie SARL, Epalinges, Switzerland) protocol (to 
discriminate cell borders) or 0.1% picrosirius red (for collagen, Sigma). The mean of the 
cardiomyocyte cross-sectional area and diameter were calculated by photomicrographs of 100 
cells/specimen with a computer assisted image analysis system (Metamorph analysis). 
Immunohistochemistry. The following primary antibodies were incubated for 2 h at 
room temperature: Mouse antibody against connexin 43 (BD Biosciences Pharmingen, Basel, 
Switzerland) and rabbit antibody against laminin (to discriminate the cell border, Sigma) used 
as primary antibodies were diluted (1:100) in PBS containing 4% of NGS whereas goat Alexa 
488 anti-mouse and goat Alexa 555 anti-rabbit were used as secondary antibodies. 
         RNA extraction and quantitative real time-polymerase chain reaction (RT-PCR). At the 
end of each experiment at sacrifice, the heart was removed and the apex was immediately 
frozen in liquid nitrogen. Total tissue RNA was extracted by using the RNeasy Mini Kit 
 
      
(Qiagen, Hilden, Germany) following the instructions of the manufacturer. Reverse 
transcriptase reaction was performed starting from 1µg of total RNA in presence of 0.5 
µmol/L of dNTP (Amersham, Otelfingen, Switzerland), 1 µg oligo dT (Promega, Mannheim, 
Germany) and 200 U/µl Superscript II (Invitrogen, Basel, Switzerland) at 42°C for 1 hour. 
For each quantitative RT-PCR reaction 1/10 of the reverse transcriptase product was used. 
RT-PCR was performed on ABI PRISM 7700 (BD Biosciences, Heidelberg, Germany) using 
Absolute QPCR ROX mix (ABgene-Axon, Baden-Dättwil, Switzerland). PCR primers and 
probes sequences were synthesized by MWG Biotech (Ebersberg, Germany). Sequences were 
the following: i) rat brain natriuretic peptide precursor (BNP) forward 5’-
CAGCTCTCAAAGGACCAAGG-3’and reverse 5’-AGAGCTGGGGAAAGAAGAGC-3’ 
with an internal probe of 5’-FAM CGCCTTCCGGATCCAGGAGAGACTTCG-3’-TAMRA; 
ii) rat GAPDH forward 5’- CCATCACTGCCACTCAGAAGAC-3 and reverse 5’-
TCATACTTGGCAGGTTTCTCCA-3’ with an internal probe of probe GAPDH rat FAM-5’-
CGTGTTCCTACCCCCAATGTATCCGT-3’-TAMRA. Expression level of mRNA was 
determined by gene-specific standard curves. Taqman results were expressed as a ratio of 
BNP over GAPDH mRNA level for each sample and normalized to the sham-operated 
controls. We verify all samples of each group and all were run in duplicate. 
             Statistical analysis. Values are reported as means ± SD. Each TTE analysis was 
repeated three times and averaged. Comparison of TTE evolution was analyzed by repeated-
measures analysis of variance. If significance was found for a variable, pairwise comparisons 
have been performed using Bonferroni’s adjustment for multiple tests. P-values <0.05 were 
considered significant. All analysis were done using the SPSS software (SPSS 11.5, SPSS 
Inc, Chicago, IL, USA).  
 
Results 
 
      
Early and late mortality.There were no deaths in the CTRL and MI groups whereas in 
the VDN group, 4/15 rats died within the first 2 weeks (early mortality rate of 27%) and 2 
died at week 5 (total mortality of 40%). In the VDN/MI group, 15/29 rats died within the first 
2 weeks (early mortality of 52%) and none died olater. 
General characteristics. At week 8, body weight (BW) was the lowest in the VDN/MI 
group (Table 1). In this group, the heart weight (HW) was significantly increased as compared 
to the CTRL group but significantly lower than in the MI group (p<0.05, Table 1). Therefore, 
their ratio HW/BW, an indicator of cardiac hypertrophy, was found elevated in both MI and 
VDN/MI groups with the highest value in the VDN/MI group (Table 1). Both VDN treated 
groups of animals exhibited significantly elevated SBP and PP (p<0.05, Table 1). The infarct 
size area was largest in the VDN/MI group as compared to the MI group (p<0.05). The lung 
weight (LW) was also measured showing that the LW/BW, an indicator of congestive heart 
failure, was the highest in the VDN/MI group (p<0.05, Table 1).  
 
 
 
 
 
 
 
 
 
 
      
 
Table 1. General characteristics of the four groups. Values are mean ± SD. BW, body weight; HW, heart weight; 
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, 
pulse pressure; IS, infarction size; LV, left ventricle; LW, lung weight; LW/BW, lung weight/body weight; * 
p<0.05 vs CTRL, † vs MI and § vs VDN. 
 
 
 
 
 
 Parameters CTRL MI VDN VDN/MI 
n 10 10 9 14 
BW (g) 463±47 481±45 421±62 402±39*† 
HW (g) 1.04±0.16 1.57±0.24* 1.23±0.08† 1.33±0.24*† 
HW/BW 2.16±0.32 2.94±0.33* 2.46±.25 3.62±0.70*†§ 
HR (bpm) 360±25 377±33 390±27 403±40* 
SBP (mmHg) 110±10 112±10 138±6*† 141±10*† 
DBP (mmHg) 80±6 81±6 91±8 92±10 
MAP (mmHg) 90±7 92±7 102±6 103±9 
PP (mmHg) 28±5 28±6 47±8*† 52±1*† 
PP/MAP (%) 28±8 22±6 38±9* 29±11 
IS 
(% IS/LV surface 
area) 
 
0 31±6* 0† 37±7*†§ 
D
em
og
ra
ph
ic
s 
LW/BW  1.03±0.29 0.83±0.26 1.02±0.09 1.23±0.15† 
 
 
 
 
      
Invasive cardiac structure and function (CC). At sacrifice, EDV and ESV values were 
augmented in the MI group as compared to the CTRL group. The SV and COc values thus 
remained within a normal range (Table 2). In contrast, in the VDN/MI group, only the ESV 
was increased and consequently SV and COc were compromised (Table 2). Contractility 
indices dP/dtmax-EDV and Ees were significantly elevated in both VDN treated groups. 
Consequently, the PE and PVA values were reduced (Table 2).  
 
      
Table 2. Invasive cardiac structure and function of the four groups (CC). Values are mean ± SD. EDV, end-
diastolic volume; ESV, end-systolic volume; SV, stroke volume; LVEDP, left ventricular end-diastolic pressure; 
dP/dtmax (preload dependent) and the preload adjusted dP/dtmax (dP/dtmax vs EDV); isovolumetric contraction 
time, ICT; Ees, end-systolic elastance; potential energy, PE; pressure-volume area, PVA; PRSW, preload 
recruitable stroke work; EFc, ejection fraction; ET, ejection time; COc, cardiac output; tau, time constant of 
relaxation; EDPVR, end-diastolic pressure-volume relationship; IRT, isovolumetric relaxation time; *  p<0.05 
vs CTRL, † vs MI and § vs VDN. 
 
 Parameters CTRL MI VDN VDN/MI 
EDV (ml) 0.27±0.05 0.39±0.12 0.18±0.04† 0.29±0.10§ 
ESV (ml) 0.11±0.04 0.22±0.08* 0.07±0.04† 0.19±0.10§ 
SV (ml) 0.15±0.03 0.17±0.06 0.11±0.03† 0.10±0.03*† 
LV
 p
re
ss
ur
es
 a
nd
 
vo
lu
m
es
 
LVEDP (mmHg) 4.9±1.8 8.6±4.0 4.9±4.0 7.4±3.3 
dP/dtmax (mmHg/ms) 7100±1300 7200±900 7900±700 8100±1500 
dP/dtmax  -  EDV 
(mmHg/s/µL) 
20±6 15±6 42±26*† 35±17† 
Is
ov
ol
um
ic
 
co
nt
ra
ct
io
n 
ph
as
e 
in
di
ce
s 
ICT (ms) 21±1 24±3 23±4 25±4 
Ees (mmHg/µL) 0.66±0.30 0.34±0.11 1.23±0.54*† 0.84±0.50† 
PE (J) 19±14 33±13 10±4.6† 15±14† 
PVA (J) 36±18 44±17 21±11† 19±8.8† 
Efficiency (%) 0.37±0.13 0.28±0.07 0.48±0.10† 0.43±0.15 
C
on
tra
ct
ile
 in
di
ce
s 
PRSW (mmHg) 77±22 79±28 103±18 91±44 
EFc (%) 59±8 44±8* 64±12† 33±7*§† 
ET (ms) 46±5 48±4 46±4 46±7 
Ej
ec
tio
n 
ph
as
e 
in
di
ce
s 
COc (ml/min) 55±11 59±17 56±26 42±12† 
Tau (ms) 13±3 16±3 11±3† 14±3 
dP/dtmin (mmHg/ms) -7600±1300 -6300±1100 -8500±900† -6900±1200§ 
EDPVR (mmHg/µL) 0.03±0.01 0.03±0.03 0.03±0.02 0.03±0.02 
A
ct
iv
e 
ph
as
e 
of
 
re
la
xa
tio
n 
in
di
ce
s 
IRT (ms) 51±3 56±3* 52±2 56±4* 
      
EFc, which decreased in the MI group, is even more perturbed in the VDN/MI group (Table 
2). LVEDP were highest in the MI groups but no statistical significance could be reached 
(Table 2). Also, minimal changes were observed with respect to timing parameters and those 
of diastolic function in all four groups (Table 2). Importantly, as clearly observed in the 
occlusion analysis curves, the MI, VDN and VDN/MI groups constitute completely different 
models of heart failure and arterial stiffening (Figure 1). 
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Figure 1. Pressure-Volume loops of the four groups showing relative ejection fractions for each group.  
 
 
 
 
 
Non-invasive cardiac structure and function (TTE). Figure 2 represents the M-mode of 
the four groups. Notice the greater RWT in the VDN group while wall motion abnormalities 
occurred in the two infarcted groups.  
 
      
 
CTRL MI 
VDN VDN/MI 
 
Figure 2. Representative TTE M-mode of the four groups at week 8. Posterior wall motion dyskinesia is visible 
in the MI and VDN/MI groups, whereas wall thickening is seen in the VDN group.  
 
The two infarcted groups presented significantly reduced EFe’s at week 8 as compared to the 
CTRL and VDN groups (Figure 3A). Also, there was no negative effect of VDN on the EFe. 
RWT is thinnest in the infarcted groups with MI group being significantly smaller vs CTRL. 
Additionally, the VDN group shows thickening compared to the CTRL group while 
significantly larger compared to the MI group (Figure 3B). The RWT is significantly affected 
by time in the combined group. The LVFS followed the trend of the EFe in the two infarcted 
groups (Figure 3C). Vcf was most compromized in the two MI groups (Figure 3D).  
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Figure 3. Serial TTE of the four groups. EFe, ejection fraction; RWT, relative wall thickness; LVFS, left ventricular fractional shortening; Vcf, velocity of circumferential fibre 
shortening; LV mass; HR, heart rate; COe, cardiac output; MPI, myocardial performance index; p<0.05 represented by an * vs CTRL, † vs MI and § vs VDN. 
      
LV mass increased in all three groups with respect to CTRL and were all significantly greater 
at week 8 (Figure 3E). HR was most compromized in the MI group (Figure 3F). COe was 
reduced in the two MI groups but no significance could be established (Figure 3G). MPI was 
highest in the MI groups but again no significance could be established (Figure 3H).  
Cardiac composition. The various parameters that we measured were not affected by 
the VDN treatment (Table 3).  
Table 3. Cardiac composition of the four groups. Values are mean ± SD. CSA, cross sectional area; BNP, brain 
natriuretic peptide. * p<0.05 vs CTRL, † vs MI and § vs VDN.  
 
 Parameters CTRL MI VDN VDN/MI 
Ca myocardial  
(µmol/g dry wt) 6.3±0.9 108±24 9.8±1.1*† 149±28*† 
Collagen (% dry weight) 6.9±0.8 15.1±1.9* 7.7±0.9† 13.2±0.8*§ 
Proteins (mg/g dry weight) 88±8 95±6 103±11 106±6 
Collagen/Protein 8.3±0.6 16.2±2.1* 7.3±0.7† 13.0±1.1§ 
Myocyte diameter (µm) 14.6±2.9 17.9±4.3* 15.3±2.9† 20.5±5.3*†§ 
Myocyte CSA (µm2 ) 221±59 346±120* 250±60† 439±164*†§ 
C
ar
di
ac
 c
om
po
si
tio
n 
BNP (pmol/L) 0.35±0.10 1.0±0.33* 0.56±0.13 1.71±0.57*†§ 
However, most alterations observed in the MI group were found to be exaggerated in the 
combined VDN/MI group of animals. Indeed, the cardiomyocyte diameter as well as the CSA 
were respectively 19% and 36 % higher in the MI group as in the CTRL group (P<0.05), 
whereas they were 29% and 50% higher in the VDN/MI group as compared to the CTRL 
group (Table 3, Figure 4).  
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A 
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Figure 4. Panel A: Cardiomyocyte hypertrophy was estimated from left ventricle section for the 4 groups. Upper 
panels show representative cardiomyocyte cross-sectional and diameter as revealed by histology using periodic 
acid schiff. Below, show cardiomyocyte length as visualized by immuhistochemistry using double staining with 
antibodies against laminin (red) and connexin 43 (green).  
Panel B: The extent of myocardial fibrosis was qualitatively visualized by picros-sirius red histological staining. 
Upper panel shows the entire cross-sectional area of the heart and downstream panel reveal same sections in a 
40x magnification. 
 
Similarly, collagen content was significantly elevated in both MI and VDN/MI groups. The 
protein levels were however comparable between all four groups (Table 3). Due to the infarct 
scar, the myocardial calcium content was, as expected, largely increased in both MI and 
VDN/MIgroups (Table 3). Although to a lesser extent, the myocardial calcium content was 
also significantly increased in the VDN group as compared to CTRL animals. Finally, the 
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mRNA expression of BNP was significantly increased in the MI group as compared to CTRL 
animals but was significantly more elevated in the combined VDN/MI group (Table 3).  
Vascular structure, function and composition. Aortic structural parameters were 
comparable between the four groups (Table 4). However the aortic functional parameters 
were largely affected by the VDN treatment. Interestingly, the combination with an MI 
advocated these alterations (Table 4). Additionally, the PWV thus the EM were elevated in 
the combined group as observed in the VDN group (Table 4). However, statistical 
significance was hampered due to large standard deviations. As expected, the aortic calcium 
was found to be highly elevated in the VDN treated animals (Table 4). Biochemistry analysis 
revealed that collagen content was increased in all groups as compared to the CTRL group 
(Table 4). Protein level was not affected by the various treatments. Finally, fibrosis was 
clearly increased in both MI groups (p<0.05, Figure 4).  
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Table 4. Aortic structure, function and composition of the four groups. Values are mean ± SD. Di, internal 
diameter; h, wall thickness; MCSA, medial cross sectional area; PWV, pulse-wave velocity; EM, elastic modulus 
and WS, wall stress. * p<0.05 vs CTRL, † vs MI and § vs VDN. 
 
 
 Parameters CTRL MI VDN VDN/MI 
Di (mm) 1.46±0.05 1.53±0.05 1.66±0.04 1.52±0.06 
h (µm) 78±4 81±4 87±3 81±5 
h/Di 0.053±0.004 0.053±0.006 0.053±0.008 0.054±0.010 
A
or
tic
 st
ru
ct
ur
e 
MCSA (mm²) 0.38±0.03 0.42±0.03 0.48±0.02 0.42±0.04 
EM 
 (106 dyne/cm2) 
5.6±4.7 5.1±2.7 19±7.9† 22±30 
WS 
(106 dyne/cm2) 
1.21±0.18 1.16±0.19 1.39±0.33 1.33±0.28 
EM/ WS 4.8±3.8 4.3±2.8 14±3.9 18±26 A
or
tic
   
fu
nc
tio
n 
PWV  (m/s) 5.1±2.0 5.0±1.5 8.8±2.5 9.5±7.3 
Ca aortic  
(µmol/g dry wt) 
17±1 15±1 442±174*† 329±143*† 
Collagen (% dry weight) 59±6 87±9* 75±10* 77±3* 
Proteins (mg/g dry 
weight) 
155±13 186±16 187±9 194±7 
A
or
tic
   
co
m
po
si
tio
n 
Collagen/Protein 39±3 47±3* 46±3 41±2 
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Discussion   
We present a novel experimental model of HF combining MI and ISH in rats. This 
model not only confirms the presence of general critical signs of advanced HF but also 
demonstrates functional, structural and biochemical cardiac alterations that are, for the 
majority of them, augmented as compared to the standard MI or VDN models. Indeed, the 
combined VDN/MI model was the only one of the three we analyzed to show significant 
weight loss, increased LW/BW and increased HW/BW. Most importantly, the ejection phase 
indices (EFc and COc) were the most compromised in this model. The systolic hypertension 
induced by the VDN treatment appears therefore to contribute substantially to the functional 
alterations provoked by the MI.  
 In the present study, the VDN treatment and the subsequent ISH influenced preferably 
the contractile parameters (dP/dtmax-EDV , PE, PVA, efficiency, PRSW, and Ees) while the MI 
affected more the diastolic function (LVEDP, IRT, dP/dtmin and tau). In addition, as opposed 
to the MI model where both EDV and ESV were increased, only the ESV parameter was 
augmented in the combined VDN/MI model. Consequently, the ejection phase indices (EFc, 
COc, SV, LVFS) were dramatically altered in the VDN/MI group of animals. This is in 
accordance with results obtained using the combination of MI plus either renal hypertension 
[4] or aortic banding [19]. Some contradictions with other observations [3,9] may be 
explained by the discrepancies of the hypertensive models ontogeny as well as by the delay 
before certain structural and functional parameters are measured. Indeed, we chose to measure 
the parameters at week 8. However, the description would certainly have been different in 
animals were followed over a longer period as demonstrated by the progressive changes 
observed in the various TTE measurements. Indeed, the increased RWT observed 2 weeks 
after VDN treatment rapidly decreased after coronary ligation even though the LV mass 
remained the highest in the combined group. In clinical situations, the prevalence of eccentric 
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hypertrophy is also typically observed in patients suffering from hypertension and having 
CHD [20] or having had a MI [21,22]. 
Cardiac composition was altered by the MI and VDN treatment. Not surprisingly, both 
groups of infarcted animals showed the highest calcium content. However, VDN treatment 
further enhanced the cardiac calcium content both in the infarcted animals and in non-
infarcted animals, confirming thus previous observation [23]. The extent of fibrosis and 
collagen levels was elevated in both infarcted groups, and was not influenced by VDN 
treatment, at least within this 8 weeks observation period. This was also observed in a model 
combining MI and SHR [24]. Finally, the cellular hypertrophy appeared to be significantly 
increased when the infarcted animals also had a VDN-induced ISH.  
BNP is an attractive parameter to follow HF evolution as it is an independent predictor 
of long term survival [25], it reflects the remodeling process in hypertension [26,27] and is 
correlated with EF [28]. In our study, the expression of BNP was the highest in the group of 
animals combining ISH and MI. These findings were also reported in clinical studies [22], 
confirming therefore the interest of the VDN/MI model for translational applications to 
clinical implications.  
In summary, the addition of hypertension on a MI model of HF largely compromises 
the cardiac function. Epidemiological studies have emphasized the close relationship between 
elevated blood pressure and the incidence of cardiovascular disease [29] and systolic blood 
pressure and pulse pressure (PP) in particular, have been demonstrated to be strong 
independent predictors of cardiovascular mortality [30,31]. Therefore, establishing an 
experimental model associating both pathologies could only be beneficial as a novel research 
tool in order to better elucidate the remodeling mechanisms involved in infarcted hearts with 
preexisting LV hypertrophy. 
 Our study may present some limitations. Combining two methods of inducing HF also 
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means combining the limitations of the two techniques. However, in the current study, the 
standard deviation observed in the VDN/MI group was in the same range as in the other 
groups. Interestingly, the infarcted surface (IS) was increased in the VDN/MI group as 
compared to the MI group even though the coronary ligation was performed in a randomized 
manner. It has indeed been proposed that the presence of LV hypertrophy is a necessary 
cofactor in the exacerbation of ischemic damage by chronic hypertension [32]. Hence, 
hypertension would augment the post-MI remodeling. Differing results might in fact have 
been obtained if the MI was performed before the VDN treatment [5]. Also, the EF which was 
lower after 4 weeks in the MI group as compared to the combined group appeared to rapidly 
stabilize in the MI group but progressively worsens in the VDN/MI group. Another limitation 
concerns the analysis of the TTE derived parameters which highly depend on the frame rate, 
resolution and intra-inter observer variability and may thus explain the differences between 
the EFc and EFe values. A difference of measurement of up to 10% between the 2 devices as 
well as a 10% intra-inter observer variability was recently reported [15].  
 
In conclusion, the addition of MI on top of a raised afterload, confirms in this small 
animal model to substantially augment the severity of HF. Therefore, the VDN/MI 
combination appropriately mimics several clinical conditions and constitutes therefore an 
attractive model to study more in-depth the development of HF and subsequently the potential 
of novel therapeutic strategies.  
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Conclusions and future perspectives 
We have employed an established model of ISH to examine the combined effects of increased 
aortic stiffness (ISH) and MI on cardiac performance and ventricular-arterial coupling in rats. 
A complete set of noninvasive (TTE) and invasive techniques were employed and a 
comprehensive set of cardiac, arterial and coupling parameters were evaluated. The major 
findings are:  
Paper 1: This paper addresses the issue of the universality of the normalized time-varying 
elastance curve. It is demonstrated that the waveform of the normalized time-varying 
elastance curve (En(tn)) is qualitatively comparable between the control and MI hearts, 
however, when En(tn) is compared quantitatively between the two groups, statistical 
significance is found at the ejection phase and during diastole. These differences need to be 
taken into account when assessing cardiac contractility based on a generalized En(tn) in 
different animal models or in the human in different physiological or pathological states.  
Paper 2: Using trans-thoracic echo (TTE), we were able to follow serial changes of cardiac 
function post MI using two novel parameters, the myocardioal performance index (MPI) and 
its ratio to left ventricular fractional shortenin (LVFS/MPI), both indices being monitor 
successfully and as efficiently as other classical TTE parameters. More so, LVFS/MPI 
visually expressed better the serial modifications in cardiac function. Both MPI and 
LVFS/MPI were correlated to the load-independent contractile parameter, PRSW, and to the 
preload parameter, LVEDP, being thus pertinent in following preload changes post MI. 
Finally, chamber remodeling post MI can successfully be followed due to the fact that ESV 
and EDV both correlate to MPI and LVFS/MPI.    
Paper 3: We studied hemodynamics, arterial function, cardiac function and ventricular-
arterial coupling in a rat model of reduced arterial compliance. The results show that arterial 
stiffening after VDN treatment provokes important changes in vascular impedance and wave 
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reflections, leading to isolated systolic hypertension and LV hypertrophy, Ventricular-arterial 
coupling was also altered. The effects are quantitatively similar to those of arterial stiffening 
with age. 
Paper 4: We studied changes in cardiac geometry, structure and function in response to MI in 
control and VDN-treated (stiffened aorta) rats. The combined VDN/MI model showed the 
largest compromise in cardiac structure and function and exhibited the strongest biochemical 
signs of heart failure as compared to all other groups. The addition of MI on top of a raised 
afterload, seems to have accelerated the progression of heart failure. Vascular alterations also 
reflected well a model of ageing and calcification. This combined pathology model of failing 
hearts in presense of a stiff arterial tree might be fruitful in better understanding the evolution 
of disease and may help improving or developing novel treatment therapies.  
 
Future perspectives:  
1. The utilization of the combined model will be employed using non viral gene transfer 
in order to elucidate the effect of gene therapy on a heart suffering from HTN and MI. 
2. Subsequently, when patients are in acute or chronic heart failure, they are placed on 
cardiac or ventricular assist devices, which offload the heart. During this period, the 
heart is capable of recovering its contractile function by a phenomenon called 
“Reverse Remodeling” (RR). Little is known about RR or understood at a molecular 
and cellular level. The intention is to perform myocardial infarctions and provoke 
arterial hypertension in rats or rabbits (even combine the two pathologies). Then, these 
damaged hearts are extracted and transplanted into the abdomen’s of recipient rats (or 
necks re rabbits) over a certain defined time period. During this period, the RR occurs, 
or not and finally the hearts will be removed at sacrifice in order to perform genomic 
and proteomic assays in order to better understand the mechanisms involved in the RR 
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process.  
3. Finally, drug discovery strategies could be defined and proposed later in collaboration 
with drug companies using MI, VDN and the combination of the two.  
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